Messages - The Tax Shelter Report
Messages - The Tax Shelter Report
Messages - The Tax Shelter Report
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
messages<br />
presents<br />
messages<br />
A film project with similarities to the already successful<br />
formula of the popular Quincy and Silent Witness television series<br />
◆<br />
Valuable tax breaks available under the EIS Scheme<br />
◆<br />
UK Distributor Blue Dolphin Film & Video have agreed<br />
to distribute <strong>Messages</strong> in the UK<br />
◆<br />
Hospitality benefits for all investors<br />
◆<br />
Experienced team of professionals to produce <strong>Messages</strong><br />
◆<br />
Potential income stream from a television series<br />
adaptation of <strong>Messages</strong><br />
Grosvenor Films Plc, Ealing Studios, Ealing Green, London W5 5EP Telephone: 020 8567 6655 Fax: 020 8758 8470<br />
Email: info@grosvenorfilms.com Website: www.grosvenorfilms.com<br />
Film Director and Co-Producer: David Fairman Co-Producers: Jon Morrey and Lynda Cope<br />
A SUPERNATURAL THRILLER<br />
Brochure designed by Addition, telephone 020 7386 4736
Contents<br />
3<br />
Offer Particulars ......................................... 4<br />
Why Invest .................................................. 5<br />
Executive Summary .................................... 6<br />
Why the Directors believe<br />
<strong>Messages</strong> will be successful ....................... 7<br />
Offer Statistics ............................................ 8<br />
Directors and Advisors ............................... 8<br />
Statement from the<br />
Company’s Directors ................................... 9<br />
<strong>The</strong> Story of the Story ...............................10<br />
<strong>Messages</strong> – <strong>The</strong> Story ................................11<br />
<strong>The</strong> Team ..............................................12-17<br />
Hospitality Benefits ...................................18<br />
<strong>The</strong> Market Today .....................................19<br />
Charts of Successful Films ........................ 20<br />
Production Schedule ................................ 20<br />
Distribution & Marketing Strategy..... 21-22<br />
Financial Information .............................. 24<br />
EIS <strong>Tax</strong> Legislation .............................. 25-26<br />
Risk Factors ............................................... 27<br />
Statatory & General Information ....... 28-32<br />
UK <strong>Tax</strong>ation & EIS Legislation ............ 33-35<br />
Accountant’s <strong>Report</strong> ........................... 36-37<br />
Procedure for Application ....................... 38<br />
Application Form &<br />
Terms & Conditions ............................ 39-40<br />
Duplicate Application Form &<br />
Terms & Conditions ............................ 41-42<br />
© Ealing Studios<br />
Definitions<br />
Grosvenor Films Plc have permanent office facilities at<br />
and operate out of Ealing Studios, the oldest film<br />
studios in the world which are still in operation.<br />
Ealing Studios, founded in 1902, were home to the<br />
famous Ealing Comedies of the 1940’s and 1950’s, and<br />
have accommodated filming for such high profile films<br />
as An Ideal Husband, Notting Hill, Star Wars: Episode 1 -<br />
<strong>The</strong> Phantom Menace, <strong>The</strong> Importance of Being Earnest<br />
and Pride and Prejudice: <strong>The</strong> Bollywood Musical.<br />
Ealing Studios are currently redeveloping their 3.8 acre<br />
site in West London at a cost of approximately £50<br />
million, including work which is already under way to<br />
build brand new film studios.<br />
“the Act”<br />
<strong>The</strong> Companies Act 1985 (as amended)<br />
“the ‘A’ Shares”<br />
<strong>The</strong> ‘A’ ordinary shares of £1 each in the capital of the Company<br />
“the ‘B’ Shares”<br />
<strong>The</strong> ‘B’ ordinary shares of £1 each in the capital of the Company<br />
“the Board” or “the Directors” <strong>The</strong> board of directors of the Company<br />
“BFI”<br />
<strong>The</strong> British Film Institute<br />
“the Company”<br />
Grosvenor Films Plc.<br />
“Costs of Production”<br />
Monies spent in the development and making of the Film<br />
“Distributable Net Profits” Gross Receipts less the Costs of Production, administrative expenses and taxation<br />
“Enterprise Investment<br />
Scheme” and “EIS”<br />
<strong>The</strong> Enterprise Investment Scheme as particularised in Chapter III of Part VII of ICTA<br />
“EIS Deferral Relief”<br />
Capital gains deferral on reinvestment pursuant to section 150C and<br />
Schedule 5B of TCGA<br />
“EIS Relief”<br />
Income tax relief and/or exemption from tax in respect of chargeable gains<br />
which is available with EIS<br />
“the Film”<br />
<strong>The</strong> proposed full-length feature film currently entitled <strong>Messages</strong><br />
“Gross Receipts”<br />
<strong>The</strong> aggregate sums, exclusive of VAT, received by the Company from the lease,<br />
license, exhibition and commercial exploitation of the Film<br />
“ICTA”<br />
Income and Corporation <strong>Tax</strong> Act 1988 (as amended)<br />
“Investors”<br />
Subscribers for ‘B’ Shares, pursuant to the Offer<br />
“the Minimum Amount” £100,000 which, in the opinion of the Directors, is the minimum amount which<br />
must be raised by the issue of the shares pursuant to the Offer<br />
“the Offer”<br />
<strong>The</strong> offer for subscription to raise up to £2,000,000 by the issue of up to<br />
2,000,000 ‘B’ Shares upon the terms and conditions of this Prospectus<br />
“Prospectus”<br />
This document including the application form<br />
“the Regulations” <strong>The</strong> Public Offers of Securities Regulations 1995<br />
“TCGA”<br />
<strong>The</strong> <strong>Tax</strong>ation of Chargeable Gains Act 1992 (as amended)<br />
Section 48 Section 48 of the Finance (No.1) Act 1997
4<br />
Offer Particulars<br />
Why Invest?<br />
5<br />
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. IF YOU ARE IN ANY<br />
DOUBT ABOUT THE CONTENTS OF THIS DOCUMENT YOU SHOULD CONSULT A PERSON AUTHORISED<br />
UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000 WHO SPECIALISES IN ADVISING ON THE<br />
ACQUISITION OF SHARES AND OTHER SECURITIES.<br />
<strong>The</strong> Directors believe it is an exciting time right now to invest in British Films<br />
A copy of this document, which comprises a Prospectus drawn up in accordance with the Public Offers of<br />
Securities Regulations 1995, has been delivered to the Registrar of Companies in England and Wales for<br />
registration as required by regulation 4(2) of the Regulations.<br />
Grosvenor Films Plc, Ealing Studios, Ealing Green, London W5 5EP<br />
telephone: 020 8567 6655 fax: 020 8758 8470<br />
email: info@grosvenorfilms.com website: www.grosvenorfilms.com<br />
(Incorporated and registered in England and Wales under the Companies Act 1995 with registered number 4877825)<br />
Offer for Subscription<br />
Offer of up to 2,000,000 new ‘B’ shares of £1 each at a price of £1 per share payable in full on application.<br />
“<br />
British Films are having their best summer at the American Box Office for more than<br />
twenty years. Last weekend four British Productions – Tomb Raider: <strong>The</strong> Cradle of Life,<br />
Johnny English, Bend It Like Beckham and 28 Days Later were in the American Top 15<br />
for takings. British cinema has not made such a sustained impact since the early 1980s and<br />
the success of Chariots of Fire and Ghandi. 28 Days Later cost £3m to make but has taken<br />
£26m during six weeks in the United States.<br />
”<br />
THE SUNDAY TIMES - 10TH AUGUST 2003<br />
Share Capital<br />
<strong>Tax</strong> Breaks via the EIS Scheme<br />
Authorised<br />
Issued and to be issued on the basis of full subscription<br />
Amount Number Amount Number<br />
£3,900,000 3,900,000 ‘B’ Shares of £1 each £2,000,000 2,000,000<br />
£100,000 100,000 ‘A’ Shares of £1 each £50,000 50,000<br />
<strong>The</strong> Directors of the Company, whose names appear on page 8 of this document, accept responsibility<br />
for the information contained in this document. To the best of the knowledge and belief of the Directors<br />
(who have taken all reasonable care to ensure that such is the case) the information contained in this<br />
document is in accordance with the facts and does not omit anything likely to affect the import of such<br />
information. <strong>The</strong> Company’s advisers named in this Prospectus act only for the Company in connection<br />
with the Offer described in this Prospectus and will not be responsible for providing the protections<br />
afforded to their clients or for advising any other person in connection with the Offer.<br />
“ “<br />
<strong>The</strong>re are valuable tax breaks on film<br />
investment. If you buy through Enterprise<br />
Investment Schemes (EIS), which have<br />
been used to fund films such as Gosford<br />
Park and Bloody Sunday, you can receive<br />
income tax relief of 20% on investments<br />
up to £ 150,000 – so long as you remain<br />
invested for at least three years. Investing<br />
in films could pay off.<br />
”<br />
THE SUNDAY TIMES, “MONEY” SECTION<br />
– 8TH JUNE 2003<br />
A cumulative total of nearly £2.2 billion<br />
was invested through the EIS between its<br />
launch and tax year 2000/01.<br />
”<br />
REPORT DATED APRIL 2003 ON RESEARCH<br />
INTO ENTERPRISE INVESTMENT SCHEME AND<br />
VENTURE CAPITAL TRUSTS – PREPARED FOR<br />
INLAND REVENUE BY NIC BOYNS, MARK COX –<br />
OF PACEC – AND PROFESSOR ALAN HUGHES,<br />
OF THE CENTRE FOR BUSINESS RESEARCH,<br />
UNIVERSITY OF CAMBRIDGE.<br />
<strong>The</strong>re at present is no listing or admission to deal on any recognised investment exchange for any shares<br />
in the Company and no application has been made. It is not intended at present to apply for any shares<br />
to be admitted to the Official List of the United Kingdom Listing Authority, to be traded on the<br />
Alternative Investment Market or otherwise admitted to dealing on a recognised investment exchange<br />
and there are not nor are there intended to be any other arrangements for there to be dealings in the<br />
shares of the Company.<br />
<strong>The</strong> Offer has not been underwritten.<br />
Benefits under the EIS Scheme<br />
◆ Income <strong>Tax</strong> relief of 20% under EIS<br />
◆ Deferral of up to 40% of Capital Gains <strong>Tax</strong> on other chargeable gains made until disposal<br />
of the shares<br />
<strong>The</strong> Offer will open at 10am on 21 October 2003. <strong>The</strong> initial closing date is 28 November 2003. So long<br />
as the Minimum Amount shall have been raised by 5pm on 28 November 2003 the Offer may then be<br />
extended by the Directors. <strong>The</strong> procedure for application is set out on page 38.<br />
◆ Capital Gains <strong>Tax</strong> relief - if an investor holds their shares for at least 3 years there is no<br />
capital gains tax charged on the gain in any sale of such shares<br />
An investment in the Company involves a significant degree of risk and may not be suitable for all<br />
recipients of this document. A prospective investor should consider carefully whether an investment in<br />
the Company is suitable in the light of their personal circumstances and the financial resources available<br />
to such investor. <strong>The</strong> entire text of this document should be read. In particular please read the section<br />
headed “Risk Factors” on page 27 of this document.<br />
Dated 21 October 2003<br />
◆ Loss relief - if the investment fails or an Investor sells their shares at a loss, that loss, after<br />
deducting EIS Income <strong>Tax</strong> relief, can be set against that Investor’s chargeable gains or<br />
taxable income<br />
More detailed information in relation to UK taxation and EIS Legislation is set out on pages<br />
25 and 26 of this document. Investors should seek their own personal tax advice.
6<br />
Executive Summary 7<br />
Why the Directors believe <strong>Messages</strong><br />
will be successful<br />
<strong>The</strong> Company’s Business<br />
◆ <strong>The</strong> Company’s principal business is the<br />
financing, production and exploitation<br />
of a full length British feature film,<br />
currently entitled <strong>Messages</strong>.<br />
◆ <strong>The</strong> Directors believe the most important<br />
aspect of the Company is that the<br />
Directors and the production team are<br />
experienced and professional film-makers<br />
who will endeavour to make the best<br />
possible film within the given budget.<br />
◆ <strong>The</strong> Directors of the Company have<br />
between them previously produced<br />
three feature films (further details of<br />
which are set out on page 9 of this<br />
document), and intend, after the<br />
completion of <strong>Messages</strong>, to produce<br />
further films with EIS Relief available<br />
to investors in those films.<br />
<strong>The</strong> <strong>Messages</strong> Project<br />
◆ <strong>Messages</strong>’ story centres around a hospital<br />
pathologist, with some similarities to the<br />
successful television series Quincy, which<br />
was made into 148 one hour episodes<br />
and repeats of which are still being<br />
broadcast on UK network television.<br />
◆ <strong>The</strong> Directors believe that because<br />
<strong>Messages</strong> is in the supernatural/thriller<br />
genre it has a greater likelihood of<br />
achieving success not only in cinemas but<br />
also on home video/DVD and that it will<br />
appeal to a wide audience base.<br />
◆ <strong>The</strong> Company has secured conditional<br />
UK cinema distribution with Blue<br />
Dolphin Film & Video, an established<br />
UK film distributor.<br />
◆ <strong>The</strong> Company has secured conditional<br />
funding for a 100 print release of <strong>Messages</strong>.<br />
◆ An investment of 14% gross of the total<br />
budget for the Film has already been<br />
agreed under a sale & leaseback<br />
arrangement.<br />
◆ <strong>The</strong> Directors believe there is potential<br />
for <strong>Messages</strong> to be adapted into an<br />
ongoing television series.<br />
Benefits to Investors<br />
◆ Investors will participate in the net<br />
profits of the Company on declaration of<br />
a dividend (further details of which are<br />
set out on page 25 of this document).<br />
◆ Under the EIS scheme investors may<br />
receive a valuable tax rebate on their<br />
total investment in the company.<br />
◆ Under the EIS scheme investors may<br />
receive profit on the sale of their shares<br />
in the Company free of capital gains tax.<br />
◆ All Investors can enjoy a number of<br />
hospitality events with the cast and crew<br />
of <strong>Messages</strong>.<br />
Key Financial Figures<br />
◆ British Films are having their best summer<br />
at the American Box Office for more than<br />
twenty years.<br />
◆ Total US box office takings in 2002 were<br />
US$9.5 billion.<br />
◆ UK cinema box office takings were up<br />
17% in 2002.<br />
◆ UK DVD sales up 111% and UK video<br />
sales were up 26% in 2002.<br />
◆ UK video retail sales in 2002 were 154<br />
Million units.<br />
Summary of Key Elements<br />
◆ <strong>Messages</strong> is in a comparable<br />
genre to and has other similarities<br />
to the successful formula of the<br />
popular Quincy and Silent Witness<br />
television series.<br />
◆ Valuable tax breaks under the EIS scheme.<br />
◆ Hospitality benefits for all investors.<br />
◆ Blue Dolphin Film & Video have<br />
conditionally agreed to distribute<br />
<strong>Messages</strong> in the UK.<br />
◆ Experienced team of professionals<br />
to produce <strong>Messages</strong>.<br />
◆ Potential income stream from a<br />
television series adaptation of <strong>Messages</strong>.<br />
Please note, for the avoidance of doubt, that Grosvenor Films Plc has no connection with Grosvenor Park<br />
Media Limited or any other Grosvenor Park company.<br />
A commercial product based around the already successful genre of<br />
the popular Quincy and Silent Witness television series<br />
<strong>The</strong> <strong>Messages</strong> storyline revolves around<br />
a pathologist, Dr. Richard Murray,<br />
attempting to solve a string of murders<br />
while being haunted by events in his own<br />
past and the psychic gifts he possesses. <strong>The</strong><br />
Directors’ decision to produce <strong>Messages</strong> was<br />
a result not only of what they saw as a<br />
creative and well written script, but also a<br />
consideration by the Directors of what<br />
genre of film was producing sustainable<br />
revenues. In doing so the Directors looked<br />
at films and television series which had<br />
historically performed well<br />
over a long period of time<br />
and which in their opinion<br />
would currently be a popular<br />
genre yet could be modified<br />
to present unique content. In<br />
terms of longevity film series<br />
such as Star Wars and Indiana<br />
Jones are obvious examples<br />
Marilyn Monroe<br />
but the Directors consider<br />
these difficult to emulate.<br />
<strong>The</strong> Directors, however, were<br />
drawn to the following:<br />
◆ Quincy ME – a television<br />
series portraying the<br />
ongoing story of the<br />
pathologist, Quincy, who<br />
Natalie Wood<br />
turns to detective work<br />
when he suspects a<br />
murder has been committed. <strong>The</strong> show<br />
was originally broadcast by the NBC<br />
network, debuted in 1976 and ran until<br />
1982, comprising 148 one hour episodes<br />
in total.<br />
Even today, 27 years after it was<br />
first broadcast, the show still enjoys<br />
repeats in the United Kingdom.<br />
<strong>The</strong> Directors believe its longevity<br />
confirms a sustainable concept in today’s<br />
international market.<br />
◆ Silent Witness – a television series<br />
portraying the life of the determined<br />
forensic pathologist, Sam Ryan, and her<br />
struggle to find the truth of the murder<br />
cases assigned to her. Sam Ryan was<br />
the creation of Nigel McCrery, a former<br />
policeman and now a writer and<br />
producer. Silent Witness debuted on<br />
BBC1 in February 1996, its sixth series<br />
is currently being broadcast in the<br />
United Kingdom on BBC1, and is also<br />
broadcast in the United States on the<br />
A&E cable network.<br />
In assessing the <strong>Messages</strong> script the<br />
Directors felt it also had the uniqueness and<br />
originality required to make <strong>Messages</strong> a<br />
success. Indeed, the entire concept of a<br />
pathologist who also has psychic gifts is<br />
believed by the Directors to be unique.<br />
In addition, the writer of the<br />
<strong>Messages</strong> script, Dr. David Kinsey, is<br />
himself a practising pathologist, a<br />
fact which the Directors believe<br />
lends the script a certain<br />
authenticity and factual<br />
accuracy.<br />
As a parallel to this,<br />
Quincy was itself inspired<br />
by the real-life<br />
Los Angeles pathologist<br />
Dr. Thomas Noguchi,<br />
John Belushi<br />
who became famous<br />
for his often controversial<br />
conclusions. Dr. Noguchi<br />
performed autopsies on many film<br />
stars, including Marilyn Monroe,<br />
Natalie Wood and John Belushi. In<br />
true Quincy style, for example, he raised<br />
doubts about the official account of Robert<br />
Kennedy’s assassination, demonstrating<br />
that Sirhan Sirhan could not have fired the<br />
fatal shot. He also acted as a technical<br />
advisor to the Quincy television show.<br />
<strong>The</strong> Directors believe the basic premise of<br />
<strong>Messages</strong> provides the opportunity for a<br />
unique spin-off television series with good<br />
scope for interesting storylines. Dr. David<br />
Kinsey is currently working on storylines<br />
for a future television series, which the<br />
Directors describe as containing elements of<br />
Quincy and Silent Witness, as well as the<br />
supernatural elements found in <strong>The</strong> X Files.<br />
To sum up, the Directors believe they<br />
have found a film investment opportunity<br />
with potential success both in terms of<br />
commercial and creative performance.
8<br />
Offer Statistics<br />
Statement from the Company’s Directors<br />
9<br />
OFFER PRICE PER ‘B’ SHARE: £1<br />
NET PROCEEDS OF THE OFFER: £1,900,000*<br />
TOTAL NUMBER OF SHARES IN ISSUE FOLLOWING THE OFFER: 2,050,000*<br />
NUMBER OF ‘B’ SHARES SUBJECT TO THE OFFER: 2,000,000<br />
PERCENTAGE OF ISSUED SHARE CAPITAL SUBJECT TO THE OFFER: 97.56%<br />
*Assuming full subscription under the Offer<br />
We firmly believe that the supernatural thriller <strong>Messages</strong> is a gripping story and we are<br />
excited about the opportunity to produce an excellent and profitable film. <strong>The</strong><br />
market for this genre of film is very strong at the moment, as demonstrated in the<br />
figures and charts on page 20 of this Document.<br />
As can be seen with films such as <strong>The</strong> Blair Witch Project, strong sales can be generated with<br />
a cast which is not well known, and we believe the <strong>Messages</strong> script can be a success without<br />
‘big-name’ actors attached to it. We will nevertheless seek to bring into <strong>Messages</strong> the most<br />
bankable actors the budget permits, and indeed will endeavour to ensure that we make the<br />
best possible film with the available budget.<br />
THIS SUMMARY SHOULD BE READ IN CONJUNCTION WITH THE FULL TEXT OF THE PROSPECTUS<br />
FROM WHICH IT IS DERIVED. ATTENTION IS DRAWN, IN PARTICULAR, TO THE SECTION HEADED<br />
“RISK FACTORS” ON PAGE 27. INDIVIDUALS CONSIDERING AN INVESTMENT IN THE COMPANY ARE<br />
STRONGLY ADVISED TO CONSULT THEIR OWN PROFESSIONAL ADVISERS.<br />
Directors and Advisors<br />
“ ”<br />
<strong>Messages</strong> has tremendous potential in all markets of the world<br />
BLUE DOLPHIN FILM & VIDEO, UK FILM DISTRIBUTORS: AUGUST 2003<br />
We are committed filmmakers and businessmen who have between us previously produced<br />
three feature films. We will use our combined experience to market, sell and distribute<br />
<strong>Messages</strong> to the best of our ability both in the cinema market and then subsequently in the<br />
video and DVD markets. We intend to follow <strong>Messages</strong> with the production of a number of<br />
other feature films.<br />
<strong>The</strong> Directors<br />
Directors<br />
David Fairman<br />
Chairman & Managing Director<br />
Ealing Studios, Ealing Green<br />
London W5 5EP<br />
Jon Morrey<br />
Commercial Director<br />
Ealing Studios, Ealing Green<br />
London W5 5EP<br />
Lee Friend<br />
Marketing Director<br />
Ealing Studios, Ealing Green<br />
London W5 5EP<br />
Company Secretary<br />
Filex Services Limited<br />
179 Great Portland Street<br />
London W1W 5LS<br />
Financial Advisor<br />
SCL Capital Partners Limited<br />
43 Howards Lane<br />
London SW15 6NX<br />
Solicitors<br />
Finers Stephens Innocent<br />
179 Great Portland Street<br />
London W1W 5LS<br />
Auditors & <strong>Report</strong>ing<br />
Accountants<br />
Bourner Bullock<br />
Chartered Accountants<br />
Sovereign House<br />
212-224 Shaftesbury Avenue<br />
London WC2H 8HQ<br />
Bankers<br />
Barclays Bank<br />
Media Banking Centre<br />
27 Soho Square<br />
London W1D 3QR<br />
Registered Office<br />
Sovereign House<br />
212-224 Shaftesbury Avenue<br />
London WC2H 8HQ<br />
David Fairman<br />
DAVID FAIRMAN<br />
Chairman and Managing Director<br />
As an established advertising photographer<br />
and film director, David has worked for many<br />
of the world’s leading advertisers and brands<br />
(including BT, British Airways, Emirates, Coca-<br />
Cola, Sony, Nestle, Persil and Lucozade).<br />
In 2000 David directed and co-produced<br />
(with Jon Morrey) his first feature film, Cold<br />
Fish, a psychological thriller which was<br />
screened at Cannes Film Festival in 2000,<br />
and was screened at a UK cinema for 8<br />
weeks from September 2001.<br />
David also directed and co-produced his<br />
second feature film in 2002, a romantic<br />
comedy entitled Lighthouse Hill. This film<br />
was financed through an EIS scheme.<br />
David has run his own film production<br />
company, Flamingo Films Limited, since<br />
2000, and it is this company that first<br />
acquired the film option for <strong>Messages</strong>.<br />
David Fairman is a member of BAFTA, <strong>The</strong><br />
New Producers Alliance and <strong>The</strong> Directors<br />
Guild of Great Britain.<br />
Jon Morrey<br />
Lee Friend<br />
JON MORREY<br />
Commercial Director<br />
Jon Morrey has gained valuable commercial<br />
skills throughout his career both as<br />
a producer and an actor. In 2000 Jon<br />
co-produced (with David Fairman) the<br />
psychological thriller Cold Fish. Jon has just<br />
finished co-producing <strong>The</strong> Prodigal, a gritty<br />
crime thriller shot in the Midlands and South<br />
London, and which is being sold internationally<br />
by Liberty International Entertainment<br />
Inc. Jon is a member of British<br />
Actors Equity, BAFTA, Royal Television<br />
Society and <strong>The</strong> New Producers Alliance.<br />
LEE FRIEND<br />
Marketing Director<br />
Lee has spent his entire working life in the<br />
photography and video industry and is<br />
actively involved in studio and production<br />
management. Lee has managed, directed<br />
and produced corporate films, pop promos<br />
and photo shoots both in the UK and Internationally<br />
for a wide variety of corporations<br />
and local government authorities.<br />
Clients include British Airways, Sainsburys,<br />
Coors Brewers, Conran, HSBC and AMEC.<br />
Internationally, Lee was responsible for<br />
sending one of the first film crews into the<br />
CIS after independence.<br />
Lee currently owns and manages <strong>The</strong> Pack<br />
Shot Company, a photographic studio in<br />
central London.
10<br />
<strong>The</strong> Story of the Story<br />
<strong>Messages</strong> – <strong>The</strong> Story<br />
11<br />
<strong>The</strong> Directors were looking for a new<br />
film to promote and decided to look<br />
for a script in the supernatural/thriller<br />
genre that had similarities to<br />
films or television series that<br />
had historically performed well<br />
over a long period of time. This,<br />
the Directors felt, would put<br />
<strong>Messages</strong> on a better footing<br />
for success.<br />
David Fairman, was attending<br />
the American Film Market<br />
in Los Angeles and was<br />
in discussion with various<br />
sales agents about potential<br />
projects. It seemed to<br />
David that the supernatural/<br />
thriller genre was the kind many<br />
people were looking for and was selling<br />
very well and without the need for well<br />
known actors in them.<br />
After a long search for a suitable script,<br />
David was sent a copy of the screenplay<br />
for <strong>Messages</strong>. David relates his experience<br />
as follows:<br />
“I just could not put this script down – to my<br />
mind this was really an exceptional script.<br />
From the first page to the very end, I was<br />
totally engaged in this gripping story of<br />
murder, mystery and the supernatural. <strong>The</strong><br />
characters were well developed and I<br />
immediately empathised with them.<br />
Another fascinating element to the script is<br />
that the writer is a working pathologist<br />
who has created a story where the main<br />
character is also a pathologist.”<br />
“Furthermore, the most important aspect<br />
of the script is that the main character and<br />
story had similarities to a popular television<br />
series that had historically performed<br />
well over a long period of time. It<br />
had similarities to the<br />
popular television series<br />
Quincy, about a pathologist<br />
who solves many of the<br />
crimes in relation to the<br />
deaths he investigates. This<br />
was just the kind of script<br />
we were looking for. Not<br />
only did I think this a great<br />
story and script but a very<br />
commercial one too.<br />
<strong>Messages</strong> will keep the<br />
audience on the edge of<br />
their seats throughout<br />
the Film. <strong>Messages</strong> includes elements<br />
reminiscent of Sixth Sense and Silence of<br />
the Lambs. As a bonus it may also be<br />
possible following the success of the movie<br />
to make a sequel, or produce a television<br />
series adapted from <strong>Messages</strong>. This was<br />
done with Lock Stock and Two Smoking<br />
Barrels and Saving Private Ryan.”<br />
Pathologist Dr. Richard Murray is on the trail of a serial killer.<br />
Are the clues he is finding being left by the dead?<br />
HELP ME, HELP ME<br />
Our hero, the renowned pathologist<br />
Dr Richard Murray is about to enter a<br />
waking nightmare. When computer<br />
<strong>Messages</strong> start appearing on his home PC<br />
pleading for help, Murray doesn’t know if<br />
someone has broken into his house or<br />
whether he’s losing his mind. But the sudden<br />
chill in the air suggests something else.<br />
Meanwhile a serial killer is on the loose,<br />
murdering beautiful young girls. When<br />
another body washes up on the shore and<br />
arrives at the hospital, Murray realises that<br />
the cryptic messages on his computer are in<br />
fact clues. Someone, somewhere wants him<br />
to find the murderer, and whoever it is<br />
knows things no one alive could ever know.<br />
Murray, a normally rational man, is forced<br />
to accept the truth – the <strong>Messages</strong> are<br />
coming from beyond the grave.<br />
Plagued by recurring memories of his<br />
wife’s recent death in a horrific car crash,<br />
Murray enters a realm where no sane<br />
human being should dwell. What ghastly<br />
secrets are buried within the shadowy<br />
surroundings of a housebound old lady?<br />
And what revelations can a spiritualist<br />
medium extract from the netherworld.?<br />
Who is this voice from the beyond? Is it a<br />
friend or a foe? And is Murray now the only<br />
person who can solve this mystery?<br />
<strong>The</strong> answer will take him through a spiral<br />
of fear to the edge of darkness, as he<br />
confronts not only the killer, but the ghosts<br />
inside himself.<br />
<strong>Messages</strong>’ taut, knife-edge conclusion brings<br />
the audience to consider those everlasting<br />
issues of love, death, grief, and the<br />
possibility of life beyond the grave that<br />
haunt us all.<br />
Statement from the Director of<br />
“<strong>Messages</strong>” David Fairman<br />
“<br />
<strong>The</strong> most important elements<br />
in any film are the Story and the Script<br />
DAVID FAIRMAN, DIRECTOR OF GROSVENOR FILMS PLC<br />
”<br />
Ibelieve that the <strong>Messages</strong> project offers myself and the Company a great opportunity to make<br />
an outstanding film with potentially excellent commercial prospects. <strong>The</strong> script sets out a story<br />
which is full of tension, the characters are complex and engaging and the Film’s ending will<br />
leave a lasting impression upon the audience. <strong>Messages</strong> deals not just with the discovery of who<br />
is the killer, but also delves into issues of love, death, bereavement and the supernatural world.<br />
<strong>The</strong> supernatural/thriller genre is in my opinion particularly popular right now, and recently<br />
successful films of such genre include Sixth Sense, <strong>The</strong> Others, House and <strong>The</strong> Ring.
12<br />
<strong>The</strong> Team<br />
<strong>The</strong> Team<br />
13<br />
David Fairman, the Film’s co-producer and director,<br />
has assembled an experienced crew and support<br />
team for the production and marketing of <strong>Messages</strong>.<br />
Many of the team have worked with David Fairman<br />
on other films.<br />
<strong>The</strong> Director and Co-Producer<br />
DAVID FAIRMAN<br />
David studied film and photography at Ravensbourne and Medway Art Colleges. He also<br />
studied acting at the Actors Centre in London and studied ‘directing actors’ at the Judith<br />
Weston Workshops in Los Angeles. David began his career as an advertising photographer<br />
and ran his own London photography studio for over 20 years. In the early 1990s David joined<br />
Picture Palace Productions in London as a commercials director, and moved into feature film<br />
production when the opportunity arose. As an established advertising photographer.<br />
David has worked for many of the world’s leading advertisers and brands (including BT,<br />
British Airways, Emirates, Coca-Cola and Sony). In 2000 David directed<br />
and co-produced (with Jon Morrey) his first feature, the dark and edgy<br />
psychological thriller Cold Fish, which was screened at Cannes Film<br />
Festival in 2000 and also screened in a UK cinema for 8 weeks from<br />
September 2001. Directing and co-producing Cold Fish enabled David<br />
to move on to his next feature film, Lighthouse Hill, which he also coproduced<br />
and directed, wrapping filming in 2002. Cold Fish is being<br />
distributed for cinema release overseas by Liberty International<br />
Entertainment Inc. (based in Los Angeles) and for United States video<br />
and DVD release by Moonlight Entertainment Inc. Lighthouse Hill is<br />
a romantic comedy shot in London and Oxfordshire starring Jason<br />
Flemyng (<strong>The</strong> League of Extraordinary<br />
Gentlemen, From Hell, Rock Star, Snatch,<br />
Lock Stock and Two Smoking Barrels), Kirsty<br />
Mitchell (Butterfly Man, A Shot at Glory), Maureen Lipman (<strong>The</strong><br />
Pianist), Frank Finlay (<strong>The</strong> Pianist), John Sessions (Gangs of New<br />
York) and Kulvindar Ghir (Goodness Gracious Me). Lighthouse Hill’s<br />
budget was approximately £1,400,000 and is currently being<br />
marketed by the sales agent First Up Films Limted.<br />
Still from the film ‘Cold Fish’<br />
What the industry has said about David:<br />
“ “<br />
Fairman‘s films and photography are<br />
sensitive, while we are lured by his utterly<br />
romantic images. Maybe it is because of<br />
Fairman’s work in advertising, that his<br />
self-inspired work is deliberately escapist<br />
and that we are constantly reminded<br />
of Dutch Still Lives or of such films as<br />
‘Le Balloon Rouge‘. Fairman attempts<br />
to encourage the public to accept<br />
photography as an art form which he has<br />
succeeded in doing so excellently.<br />
”<br />
C. MAURICE: ARTS REVIEW<br />
British photographer David Fairman has<br />
won the top award in the entertainment<br />
section of the International Association<br />
for Multi-Images Competition held<br />
recently in Los Angeles. <strong>The</strong> award was<br />
for the British Airways AV presentation of<br />
their 1986 calendar. Starting in London<br />
Fairman travelled around the world<br />
taking in Dubai, Rio, China and Africa.<br />
”<br />
BRITISH PHOTOGRAPHIC INDUSTRY NEWS.<br />
JON MORREY<br />
Jon Morrey (Stage name: “Jon-Paul Gates”)<br />
holds an HND at distinction level in Business<br />
and Finance, and completed 2 years<br />
on BA(Hons) Combined Studies degree in<br />
business and finance at Humberside<br />
Polytechnic. In addition, Jon also trained as<br />
an actor at Humberside Polytechnic and<br />
starred in Eldorado (a BBC1 production)<br />
as well as having worked in<br />
the independent film<br />
scene both in the UK<br />
as well as abroad.<br />
Jon has starred in 6<br />
feature films including<br />
<strong>The</strong> Hawk & the Dove,<br />
Cold Fish, Winter<br />
Warrior and Red Rose.<br />
Stephen Kral of Seventh<br />
Art Releasing<br />
writes about Jon:<br />
“He is a ‘method’ artist who would do<br />
Stanislavsky proud… he is a very talented<br />
actor… with the right guidance, I expect<br />
him to become a performer of considerable<br />
stature in the future.”<br />
Jon has co-produced the ‘short’ film,<br />
Payday, a 26 minute pilot for a<br />
television series made for Central T.V.<br />
In 2000 Jon co-produced (with David<br />
Fairman) the psychological thriller Cold<br />
Fish, further details of which<br />
are set out under David<br />
Fairman’s name on page 12.<br />
Jon has just finished coproducing<br />
<strong>The</strong> Prodigal, a<br />
gritty crime thriller shot in the<br />
Midlands and South London.<br />
Co-Producers<br />
LYNDA COPE<br />
Lynda Cope graduated<br />
in 1975 from Bristol<br />
University with a degree<br />
in European literature,<br />
and Lynda has worked<br />
in Brussels with the<br />
European Commission<br />
as a terminologist.<br />
Upon her return to<br />
the UK, Lynda held a<br />
marketing position<br />
with Invicta Capital Limited.<br />
Lynda joined Sky Television on its launch in<br />
1989, and handled the marketing of their<br />
channels in the UK.<br />
In 1993, Lynda set up A&C Associates, a<br />
consultancy specialising in the financing of<br />
pan-European broadcasts. She has worked<br />
with a variety of clients across Europe.<br />
Lynda’s role as co-producer will be to<br />
liaise with the Company’s financial and<br />
distribution partners for <strong>Messages</strong>.<br />
Stills from the film ‘Cold Fish’<br />
Poster and still from the film ‘<strong>The</strong> Prodigal’
14<br />
<strong>The</strong> Team<br />
<strong>The</strong> Team<br />
15<br />
Writer<br />
DR WAYNE KINSEY<br />
Dr. Kinsey is a practising consultant pathologist<br />
based in Norfolk, having studied<br />
medicine at Birmingham Medical School. Dr.<br />
Kinsey has many years of experience in the<br />
field of pathology.<br />
In 1971, at the age of ten, after watching the<br />
exploits of Baron Frankenstein on late<br />
night television, Dr. Kinsey became an avid<br />
“Hammer horror” fan and he has not been<br />
the same since.<br />
Dr. Kinsey is one of the country’s leading<br />
authorities on Hammer horror films. He<br />
owns a large collection of Hammer horror<br />
memorabilia and produces a successful<br />
magazine about the Hammer company<br />
called <strong>The</strong> House That Hammer Built,<br />
which is sold worldwide.<br />
Dr Kinsey has written a<br />
successful book on the<br />
subject, Hammer Films -<br />
<strong>The</strong> Bray Studios Years,<br />
which was published in<br />
2002, was well received<br />
and has already been re-printed<br />
once. In addition Dr. Kinsey is currently<br />
penning a follow-up book on the subject:<br />
Hammer Films - <strong>The</strong> Elstree Studios Years.<br />
Cinematographer/<br />
Director of Photography<br />
TONI IMI<br />
Toni is the most experienced member of our<br />
crew who, during his career as a cinematographer,<br />
has made seventy seven feature<br />
films and major television productions.<br />
Toni won the Santa Monica Film Festival<br />
Movie Award for Best Director of Photography<br />
for Testimony of Talisman Jones.<br />
Toni was the cinematographer on David<br />
Fairman’s last film, Lighthouse Hill, and<br />
is very much looking forward<br />
to working with David again.<br />
In his long career Toni has<br />
worked with Tatum O’Neal<br />
and Anthony Hopkins in<br />
International Velvet, Roger<br />
Moore, James Mason &<br />
Anthony Perkins in North Sea<br />
Hi-Jack, Gregory Peck & David Niven in <strong>The</strong><br />
Sea Wolves: <strong>The</strong> Last Charge of the Calcutta<br />
Light Horse, Phil Collins & Julie Walters in<br />
Buster, Andy Garcia in American Roulette,<br />
Nicholas Cage, Tommy Lee Jones & Sean<br />
Young for Fire Birds, Jude Law & Sadie Frost<br />
in Shopping, Woody Allen & Peter Falk in<br />
<strong>The</strong> Sunshine Boys & Joseph Fiennes and<br />
Tara Fitzgerald in Rancid Aluminium.<br />
Jude Law © Rex Features<br />
Editor<br />
ALAN STRACHAN<br />
Alan Strachan edited David Fairman’s last<br />
film Lighthouse Hill and is looking forward<br />
to working again with David on <strong>Messages</strong>.<br />
Alan began his career as assistant editor on<br />
the film Casino Royale which starred Peter<br />
Sellers, David Niven, Orson Welles And<br />
Woody Allen.<br />
Those films which Alan<br />
has edited throughout<br />
his career include <strong>The</strong><br />
Final Conflict starring<br />
Sam Neill, cult film<br />
Withnail and I starring<br />
Richard E. Grant, Paul<br />
McGann and Michael<br />
Elphick, Shooting Fish starring Kate<br />
Beckinsale and Saving Grace starring<br />
Brenda Blethyn and Martin Clunes.<br />
Music Composer<br />
CHRISTOPHER GUNNING<br />
Christopher Gunning has worked with<br />
David Fairman before and composed some<br />
memorable music for Lighthouse Hill.<br />
<strong>The</strong> Directors are honoured to have<br />
Christopher, a winner of three BAFTA<br />
Awards, on the team for <strong>Messages</strong>.<br />
Christopher has won BAFTA Awards for Best<br />
Original Television Music in 1988 for<br />
Porterhouse Blue, 1990 for Poirot, and 1995<br />
for Middlemarch. Christopher is<br />
particularly known for his<br />
edgy music for the television<br />
series Poirot.<br />
Christopher’s feature film work<br />
includes composing the music for<br />
Under Suspicion starring Liam<br />
Neeson and the television films<br />
Murder in Messopatania starring<br />
David Suchet and Rebecca starring Charles<br />
Dance & Faye Dunaway.
16<br />
<strong>The</strong> Team<br />
<strong>The</strong> Team<br />
17<br />
Sound Mixer<br />
GARETH BULL & ANVIL POST PRODUCTION<br />
David Fairman worked with Gareth Bull and Anvil<br />
for the post production aspects of Lighthouse Hill.<br />
David was impressed by their professionalism and<br />
commitment to quality, and so the Directors have<br />
brought them onto the team for <strong>Messages</strong>. Anvil also produced<br />
the final mix on David Fairman’s first feature film, Cold Fish.<br />
Gareth has previously worked on the sound desk for Harry Potter<br />
and the Chamber Of Secrets, Harry Potter and the Sorcerers Stone<br />
and East Is East.<br />
Daniel Radcliffe (AKA Harry Potter)<br />
© Rex Features<br />
Special Effects<br />
BOB KEEN & SFX<br />
AT PINEWOOD STUDIOS<br />
Bob Keen has worked within SFX for 27 years and<br />
produced the practical special effects and the<br />
computer generated effects for David Fairman’s last<br />
film, Lighthouse Hill. Bob’s previous experience include working on the special effects, visual<br />
effects or special make-up effects for Alien, Dog Soldiers, Event Horizon, Star Wars - Episode<br />
IV (1977), and Star Wars - Episode V: <strong>The</strong> Empire Strikes Back.<br />
Financial Advisor<br />
Bob and Pinhead<br />
Casting Director<br />
PETER SABINE OF SCL<br />
CAPITAL PARTNERS LTD<br />
Ewan Mcgregor © Rex Features<br />
SARAH TREVIS<br />
Sarah is an experienced casting director and<br />
has cast some very well known and talented<br />
names for the films she has worked on.<br />
She has cast films with some of the best UK<br />
and US talent available, and the Directors<br />
are extremely pleased that she has agreed<br />
to cast <strong>Messages</strong>.<br />
Actors she has previously<br />
cast include Ewan<br />
Mcgregor in Shallow<br />
Grave, Michael Douglas<br />
and Val Kilmer in <strong>The</strong><br />
Ghost and Darkness,<br />
Albert Finney and Julie<br />
Christie in Karaoke,<br />
Peter O’Toole and Harvey Keitel in<br />
Fairy Tale: A True Story,<br />
Tim Roth, Rupert Everett<br />
and Olivia Williams in<br />
To Kill a King, Gwyneth<br />
Paltrow and Toni<br />
Collette in Emma, and<br />
Ralph Fiennes in the<br />
<strong>The</strong> Miracle Maker.<br />
Gwyneth Paltrow © Rex Features<br />
Publicity Strategy<br />
DAVID SHAW<br />
David Shaw worked as a publicity<br />
agent on David Fairman’s film Cold<br />
Fish. David has many years of brand<br />
building, PR & marketing experience<br />
and has worked with numerous film,<br />
television and media clients. David’s<br />
experience includes working for Channel 4<br />
as Senior Publicity Manager for FilmFour,<br />
devising and implementing both corporate<br />
and consumer strategies and developing<br />
synergies between the production, distribution<br />
and dedicated film channels. Other<br />
clients include the BBC, Edinburgh International<br />
Film Festival, MEDIA Programme,<br />
the European Film Awards, the Indian<br />
Government Film and Broadcasting Division,<br />
NBD TV, High Point Film & Television and<br />
Minatour. He has also worked closely as a<br />
personal publicist with film directors such as<br />
Shekhar Kapur (who directed Elizabeth and<br />
<strong>The</strong> Four Feathers) and Jim Gillespie (who<br />
directed I Know What You Did Last Summer).<br />
© Rex Features<br />
Marketing Director<br />
LEE FRIEND<br />
Lee has spent his entire working life in the<br />
photography and video industry and is actively<br />
involved in studio and production management.<br />
Lee has managed, directed and produced<br />
corporate films, pop promos and photo shoots<br />
both in the UK and Internationally for a wide<br />
variety of corporations and local government<br />
authorities. Clients include British Airways,<br />
Sainsburys, Coors Brewers, Conran, HSBC and<br />
AMEC. Internationally, Lee was responsible for<br />
sending film crews into the CIS and the<br />
Tajakistan development agency after independence<br />
was declared. Lee currently owns and<br />
manages <strong>The</strong> Pack Shot Company, a photographic<br />
studio in central London. Lee has worked<br />
extensively producing visual imagery for clients<br />
of <strong>The</strong> Pack Shot Company. He will be planning<br />
and implementing the publicity and internet<br />
campaigns for <strong>Messages</strong>. He will also take<br />
personal charge of the hospitality and social<br />
events that will surround the film.<br />
Peter is co-founder and director of SCL<br />
Capital Partners, an FSA regulated<br />
corporate finance advisory firm<br />
established in 1999. He is an ex Price<br />
Waterhouse chartered accountant and<br />
is also a former director of ANZ<br />
Merchant Bank based in the City of<br />
London. Peter has some 30 years of<br />
corporate finance experience, the last<br />
10 years of which have been spent in<br />
venture capital. Much of his career has<br />
been spent in international and<br />
investment banking working for prime<br />
Swiss, US and UK banks prior to<br />
forming his own corporate finance<br />
practice in 1993.
18<br />
Hospitality Benefits <strong>The</strong> Market Today<br />
19<br />
Additional Hospitality<br />
Benefits for Investors<br />
Apart from the potential tax savings and the<br />
profit generating potential of <strong>Messages</strong>,<br />
Investors will receive added social benefits<br />
from investing in the Company.<br />
All Investors will be invited to the various<br />
social events to be organised at various<br />
points in the Film’s pre-production and<br />
production. Investors will have the opportunity<br />
to see with their own eyes how a<br />
film is really made and become part of the<br />
film-making community.<br />
If you invest in <strong>Messages</strong><br />
you will receive:<br />
1<br />
2<br />
1<br />
2<br />
“<br />
Cinema admissions in the UK are at their<br />
highest for almost 30 years. Total box office<br />
receipts totalled £755 million, which is a<br />
175% increase on the last decade, and 17%<br />
more than 2001.<br />
”<br />
BBC NEWS/ENTERTAINMENT WEBSITE,<br />
8 JUNE 2003<br />
“<br />
<strong>The</strong> Movie Industry is one of most exciting<br />
and informative businesses in the world, a<br />
business where the revenue of a single<br />
feature film (such as Titanic) can approach or<br />
exceed $1 billion. In 2001, worldwide gross<br />
revenues generated by motion pictures in all<br />
territories and media (including music and<br />
ancillaries) amounted to over $40 billion.<br />
”<br />
REPORT BY JAMES JAEGER,<br />
FROM WWW.MECFILMS.COM<br />
Video and DVD Market<br />
It is the DVD market, introduced in 1999<br />
and with a high rate of growth, which<br />
interests the Directors the most in terms of<br />
generating potential revenue.<br />
◆ UK DVD sales are up by 111% from<br />
2001 to 2002.<br />
◆ <strong>The</strong> overall video market up by 26%<br />
from 2001 to 2002.<br />
◆ UK video retail sales increased to 154<br />
million units in 2002.<br />
<strong>The</strong>re are three supernatural/thriller genre<br />
films in the BFI all time top 20 rental video<br />
chart, being <strong>The</strong> Sixth Sense (No. 8) Ghost<br />
(No. 10) and <strong>The</strong> Green Mile (No. 11).<br />
◆ An invitation for you and your spouse/<br />
partner to a pre-production party where<br />
you can meet the producers, the director,<br />
the writer and crew members together<br />
with some of the stars of <strong>Messages</strong>.<br />
◆ An invitation for you and your spouse/<br />
partner to visit the film set for a whole<br />
day and possibly a chance to appear as<br />
an extra in the Film.<br />
◆ An invitation for you and your spouse/<br />
partner to a Gala screening of <strong>Messages</strong><br />
at a West End cinema, followed by a<br />
cocktail party with stars from <strong>Messages</strong><br />
and other film and television celebrities.<br />
1. <strong>The</strong> Director David Fairman with HRH Princess<br />
Michael of Kent at the party after the premier<br />
screening of Lighthouse Hill.<br />
2. David Fairman and Jon Morrey at the party after<br />
the premier screening of Cold Fish.<br />
3. David Fairman and Tony Imi on the set of Lighthouse Hill.<br />
4. David Fairman, Jason Flemyng and Maureen Lipman<br />
discussing script changes on the set of Lighthouse Hill.<br />
5. <strong>The</strong> writer Dr. Wayne Kinsey and Christopher Lee<br />
at a book signing event.<br />
6. Hospitality Boats in the Harbour during the Cannes<br />
Film Festival.<br />
3<br />
4<br />
5<br />
6<br />
3<br />
4<br />
5<br />
6<br />
<strong>The</strong> Cinema Market<br />
<strong>The</strong> Directors believe it is an excellent time<br />
right now to invest in British Films.<br />
“<br />
British Films are having their best summer<br />
at the American Box Office for more than<br />
twenty years. Last weekend four British<br />
Productions - Tomb Raider: <strong>The</strong> Cradle of<br />
Life, Johnny English, Bend It Like Beckham<br />
and 28 Days Later were in the American<br />
Top 15 for takings. British cinema has not<br />
made such a sustained impact since the<br />
early 1980s and the success of Chariots of<br />
Fire and Ghandi. 28 Days Later cost £3m to<br />
make but has taken £26m during six weeks<br />
”<br />
in the United States.<br />
SUNDAY TIMES AUGUST 10TH 2003<br />
◆ Worldwide box office receipts for<br />
feature films have grown from $1.2<br />
billion in 1970 and $2.8 billion in 1980 to<br />
over $15 billion in 2001.<br />
◆ <strong>The</strong> supernatural/thriller film <strong>The</strong> Others<br />
was the number one EU made film at the<br />
UK Box Office in 2001 with gross box<br />
office takings in the UK of £11,655,000.<br />
Cable Television<br />
Markets<br />
<strong>The</strong> number of pay per view cable<br />
customers in the United States is over<br />
20 million, up from 6 million in 1989.<br />
Combined United States cable sales revenue<br />
totals approximately 20% of United States<br />
cinema box office revenues.<br />
Demographics<br />
Of the total U.S. population of approximately<br />
265 million, the two largest groups that go to<br />
the cinema are 16-20 year-olds and 30-39<br />
year-olds. Each such age group makes up<br />
approximately 19% of the cinema-going<br />
population. In the United States viewers<br />
under the age of 30 are currently and<br />
historically have been, the dominant force in<br />
general the cinema-going public.
20<br />
Charts of Successful Films Distribution & Marketing Strategy 21<br />
Comparable Films Analysis<br />
For illustrative purposes only the Directors have included below two charts recording the<br />
box office receipts of four recent successful British films and four successful films in<br />
the same genre as <strong>Messages</strong>. Each chart shows the total production cost compared to<br />
the maximum gross United States and European box office receipts (where available).<br />
<strong>The</strong>se figures exclude television sales, pay per view, video or DVD sales.<br />
Successful recent British films<br />
£ Sterling 1,000‘s<br />
140<br />
120<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
35,212<br />
3,000<br />
US & European Box Office<br />
Production Cost<br />
40,269<br />
5,000<br />
Bend it like<br />
Beckham<br />
28 Days<br />
Later<br />
67,878<br />
21,875<br />
138,228<br />
16,250<br />
Johnny<br />
English<br />
Bridget Jones’<br />
Diary<br />
<strong>The</strong> charts above are merely illustrative and are not predictions or guarantees.<br />
Included in these charts is the most profitable film ever made, <strong>The</strong> Blair Witch Project (also in<br />
the supernatural/thriller genre) which was made for £22,000 and has recorded gross US<br />
& European box office receipts of £102,000,000 representing a 463,636% return on its<br />
budget. This film did not have any well known or bankable actors in the cast.<br />
Production Schedule<br />
Successful films in the same genre as <strong>Messages</strong><br />
£ Sterling 1,000‘s<br />
200<br />
150<br />
100<br />
50<br />
0<br />
12,153<br />
1875<br />
House<br />
US & European Box Office<br />
Production Cost<br />
98,601<br />
10,625<br />
<strong>The</strong> Others<br />
It is anticipated that the filming of <strong>Messages</strong> will commence in the<br />
Spring of 2004 and will take approximately six weeks. <strong>The</strong> Directors<br />
aim to shoot as much of <strong>Messages</strong> as possible on location to<br />
maintain a realistic feel. <strong>The</strong> post-production process (editing, sound,<br />
dubbing, etc) is expected to take up to three months, and the<br />
Directors therefore anticipate that post-production will be<br />
completed by the late Summer of 2004. <strong>The</strong> Directors are planning<br />
a UK cinema release for November 2004.<br />
102,732<br />
22<br />
208,845<br />
34,375<br />
<strong>The</strong> Blair<br />
Witch Project<br />
<strong>The</strong> Sixth<br />
Sense<br />
“ ”<br />
<strong>Messages</strong> has tremendous potential in all markets of the world<br />
Blue Dolphin Film<br />
& Video<br />
UK Distributor Blue Dolphin Film & Video<br />
(“Blue Dolphin”) have, subject to approval<br />
of the script and £250,000 of funding<br />
being available for the purpose, agreed<br />
to provide the cinema distribution of<br />
<strong>Messages</strong> in the UK and to guarantee a 100<br />
print initial release of <strong>Messages</strong>.<br />
Established in 1980 by Joseph D’Morais,<br />
Blue Dolphin is one of the longest running<br />
independent film distributors in the UK.<br />
By employing its own in-house PR and<br />
marketing team for cinema, DVD and video<br />
releases Blue Dolphin seeks to use<br />
innovative sales patterns to exploit films’<br />
maximum revenue potential.<br />
Blue Dolphin currently has over two<br />
thousand films in distribution, including<br />
many MGM/United Artists films.<br />
Ingenius Media Ltd<br />
<strong>The</strong> cinema distribution of <strong>Messages</strong> will be<br />
financed through a sale and leaseback<br />
finance arrangement. <strong>The</strong> Company already<br />
has an offer contract from the sale and<br />
leaseback specialists Ingenius Media<br />
Limited to contribute 14% gross of the<br />
budget of the Film under Section 48.<br />
Ingenius will not require their funding<br />
contribution to be repaid to it, but instead<br />
will require as consideration for their<br />
funding, 2.5% of the gross profits of<br />
<strong>Messages</strong>. <strong>The</strong> directors consider this<br />
financially advantageous for the financing<br />
of the UK cinema distribution of <strong>Messages</strong>.<br />
BLUE DOLPHIN FILM & VIDEO<br />
This funding will be used to finance a print<br />
and advertising campaign for the UK<br />
cinema distribution release of <strong>Messages</strong>.<br />
Example: If the budget of the Film were<br />
£2,000,000 then Ingenius could contribute<br />
14% gross of the budget, equivalent to<br />
£280,000 for the financing of a UK prints<br />
and advertising campaign.<br />
<strong>The</strong> Sales Agent<br />
Following finalisation of the cast, the<br />
Company will engage such sales agent as<br />
the Directors consider to be the best<br />
available to promote and sell <strong>Messages</strong><br />
in the United States, European and other<br />
world territories.<br />
<strong>The</strong> UK cinema release is intended to be the<br />
engine that will drive international sales.<br />
<strong>The</strong> sales agent will sell the available rights<br />
to exhibit <strong>Messages</strong> to distributors and<br />
television companies around the world.<br />
Usually the sales agent implements<br />
marketing campaigns for a film aimed at<br />
maximising its positive exposure. <strong>The</strong> sales<br />
agent often has strong relationships with<br />
many distributors, and in order to make sales<br />
to these distributors, the sales agent normally<br />
promotes a film at major film markets such as<br />
Cannes and the American Film Market.<br />
<strong>The</strong> Company is already in negotiation with<br />
Echelon/RGH Lion’s Share, a US distributor<br />
to deal with international distribution,<br />
though as yet no contract has been signed.<br />
Overseas Distribution<br />
<strong>The</strong> Directors believe that <strong>Messages</strong> has<br />
a story and is in a genre that should<br />
have international appeal both in cinemas<br />
and on a video/DVD release. Overseas<br />
distribution of <strong>Messages</strong> will be sold by our<br />
sales agent.
22 Distribution & Marketing Strategy<br />
Television Sales<br />
and Pay per View<br />
UK and foreign pay per view and television<br />
sales will be sought by the sales agent after<br />
the cinema distribution has been put in place.<br />
Video & DVD<br />
It is intended that Blue Dolphin Film &<br />
Video will be appointed to handle video<br />
and DVD distribution in the UK.<br />
<strong>The</strong> sales agent will handle all foreign<br />
video and DVD sales when it attends<br />
international film festivals and markets.<br />
<strong>The</strong> Directors believe that the video and<br />
DVD market is currently very receptive to<br />
the supernatural/thriller film genre.<br />
Film Festivals and<br />
Film Markets<br />
<strong>The</strong> Company will plan a schedule of<br />
American and foreign film festivals and<br />
markets to attend in order to showcase and<br />
sell <strong>Messages</strong>.<br />
Ancillary Markets<br />
<strong>The</strong> Directors will also seek sales to airlines<br />
and will endeavour to promote sales from<br />
any soundtrack of the music used in<br />
<strong>Messages</strong> and any other merchandising<br />
opportunities that arise from the production.<br />
Publicity/Marketing<br />
Strategy<br />
During filming our film publicist, David Shaw,<br />
will endeavour to arrange magazine and<br />
newspaper feature articles about <strong>Messages</strong><br />
and interviews with the cast and production<br />
team. Such articles and interviews will then<br />
be used to publicise <strong>Messages</strong> before and<br />
during its cinema distribution.<br />
<strong>The</strong> fact that the writer of the film, Dr.<br />
Wayne Kinsey, is a practising pathologist<br />
will be used to garner added interest in<br />
<strong>Messages</strong>.<br />
<strong>The</strong> Internet<br />
<strong>The</strong> Company will plan and execute its own<br />
original internet marketing plan before the<br />
cinema release of <strong>Messages</strong>. This will seek<br />
to increase awareness of sales of the film.<br />
“<strong>Messages</strong>”<br />
Television Series<br />
<strong>The</strong> writer, Dr. Wayne Kinsey, has already<br />
written various storylines for episodes of a<br />
possible television series based on <strong>Messages</strong>.<br />
<strong>The</strong> Company and its producers will present<br />
this concept to television companies in the<br />
UK and the United States at major<br />
television festivals and markets. It is<br />
expected that such a television series would<br />
be financed by a UK or United States<br />
television company.<br />
<strong>The</strong> Company has acquired and retains the<br />
rights on the exploitation of <strong>Messages</strong> as a<br />
television series.<br />
A <strong>Messages</strong> television series could also have<br />
potential for sales to other territories. Senior<br />
industry sources have indicated that they<br />
believe that currently approximately 25% of<br />
UK originated television programming has<br />
genuine overseas sales potential.<br />
Any television series could provide extra<br />
revenue to the Company after the initial<br />
release of <strong>Messages</strong>.<br />
<strong>The</strong> DTA have published figures showing<br />
that UK television exports increased from<br />
$504 million in 1998 to $532 million in 1999.<br />
Financial<br />
Information
24<br />
Financial Information EIS tax legislation<br />
25<br />
Budget<br />
A maximum of £2,000,000 is to be raised under the Offer, which will be used to fund the production of<br />
the Film and the expenses of the Offer.<br />
<strong>The</strong> Minimum Amount required to cover the costs of production of a film suitable for television or video<br />
release only and the initial expenses of the Offer is £100,000. If only the Minimum Amount is raised, the<br />
Directors intend to make a film suitable for television or video release. In order to shoot a film for this<br />
budget we would film on video tape and the crew and actors fees will be deferred.<br />
If the Offer is less than fully subscribed or if the budget has to be increased, the Directors may seek to<br />
raise additional finance to complete the Film. Such additional finance may be obtained through a<br />
combination of loans from third parties, other qualifying tax schemes or by paying the crew, cast,<br />
equipment suppliers and other key personnel on a deferred basis. <strong>The</strong> Director and Producers of the Film<br />
have agreed to accept deferred payments while other potential members of the team have not yet<br />
agreed. Any loan repayments or deferred payments will have to be made out of Gross Receipts before<br />
Investors receive any return on their investment.<br />
Dividend Policy<br />
<strong>The</strong> Directors expect to retain any profits in the Company for a period of three years from the closing<br />
date of the Offer. Dividends may be paid in subsequent years following this initial three year period.<br />
Realisation of Investment<br />
After three years, the Directors intend to seek the view of shareholders regarding the provision of a<br />
means of realising their investment. <strong>The</strong>re may be a number of alternatives available, such as the sale of<br />
part or the whole of the Company, the purchase by the Company of shares held by shareholders, the<br />
introduction of new investors, the voluntary liquidation of the Company or the sale of the Company's<br />
assets and subsequent distribution of proceeds to shareholders. Other opportunities may also arise over<br />
the next three years, and the Directors will consider the most appropriate method having regard to the<br />
Company's position and requirements at the time, and make a recommendation to the shareholders.<br />
Details of the Offer<br />
Up to 2,000,000 'B' Shares are being offered at a price of £1 per share, payable in full upon application.<br />
Applications must be for a minimum of 2,000 ‘B’ Shares and thereafter in multiples of 1,000 ‘B’ Shares,<br />
provided the applicant's shareholding does not exceed 29.9% of the total number of ‘B’ Shares in issue<br />
after the Offer closes.<br />
<strong>The</strong> Offer will open at 10am on 21 October 2003. <strong>The</strong> initial closing date is 28 November 2003. So long<br />
as the Minimum Amount shall have been raised by 5pm on 28 November 2003, the Offer may then be<br />
extended by the Directors.<br />
If the Offer is oversubscribed, the Directors can exercise their discretion to scale down applications or,<br />
pursuant to their general power under the articles of association, to accept the applications and allot<br />
shares accordingly. If the Offer is less than fully subscribed, the amount of capital subscription will be<br />
allotted and issued, provided the Minimum Amount has been achieved. If the Minimum Amount is not<br />
raised within 40 days of the issue of this Prospectus, the Film will not proceed, and applicants will be<br />
refunded their subscription money in full within 7 days of the final closing date of the Offer.<br />
<strong>Report</strong>ing to Shareholders<br />
<strong>The</strong> Company will issue an annual report to each shareholder, informing them of the progress of the Film<br />
and the financial position of the Company. <strong>The</strong> accounting reference date of the Company is 31 August<br />
and its first audited accounts will be produced for the financial period from its incorporation to<br />
31 August 2004 and will be filed at Companies House before the filing deadline of 31 March 2005.<br />
In addition, the Directors intend to produce occasional informal newsletters or information on the<br />
Company’s website informing Investors of progress.<br />
EIS tax legislation<br />
Further information on the EIS is to be found on pages 33-35 of this document.<br />
However, a summary of the key tax incentives are set out below.<br />
1. How you can benefit<br />
Eligible Investors should be able to benefit from various EIS tax reliefs as follows:<br />
Type of Relief Maximum rate Maximum annual investment Maximum tax you can save<br />
EIS income tax relief 20% £150,000 per individual £30,000 per individual<br />
EIS capital gains tax deferral 40% No upper limit No upper limit<br />
2. How much tax therefore can I potentially save/defer when I invest?<br />
Amount invested <strong>Tax</strong> relief Net cost to you<br />
(i) Investors claiming EIS income tax relief £10,000 £2,000 £8,000<br />
(ii) Investors claiming EIS CGT deferral £10,000 £4,000 £6,000<br />
(repayable when the<br />
investment is realised<br />
or ceases to qualify)<br />
(iii) Investors claiming both £10,000 £2,000 (income tax relief) £4,000<br />
EIS income tax relief and CGT deferral<br />
£4,000 (CGT deferral<br />
repayable when the<br />
investment is realised or<br />
ceases to qualify)<br />
Eligible Investors may therefore be able to combine the above reliefs so as to achieve initial reliefs of 60p<br />
in the £1. Examples (ii) and (iii) are calculated on the assumption that you would otherwise pay tax at<br />
40% on the chargeable gain.<br />
3. What would happen if I were to sell my ‘B’ Shares after 3 years at a profit?<br />
You will not have to pay any tax at all on any profits made from the sale of your ‘B’ Shares which have<br />
qualified for income tax relief if you sell them after three years.<br />
<strong>The</strong> tables below demonstrate the percentage returns that an Investor would receive if his/her ‘B’ Shares<br />
were sold at £2.40 per share compared to the original purchase price of £1 per share.<br />
Table (a)<br />
Net cash amount invested for 10,000 ‘B’ Shares £8,000<br />
(assuming only income tax relief at 20% applied)<br />
Cash received after sale of 10,000 ‘B’ Shares £24,000<br />
Net cash profit received from sale of 10,000 ‘B’ Shares £16,000<br />
Percentage return on net cash amount invested 200%<br />
Table (b)<br />
Net cash amount invested for 10,000 ‘B’ Shares £4,000<br />
(this assumes both CGT deferral at 40% and income tax relief at 20% have been applied)<br />
Cash received after sale of 10,000 ‘B’ Shares £24,000<br />
Less repayment of CGT deferral from year 1 £4,000<br />
Net cash profit received from sale of 10,000 ‘B’ Shares £16,000<br />
Percentage return on net cash amount invested 400%<br />
<strong>The</strong> example given in table (a) assumes only income tax relief at 20% has been applied. <strong>The</strong> example<br />
given in table (b) assumes both CGT deferral at 40% and income tax relief at 20% have been applied.
26<br />
EIS tax legislation Risk Factors 27<br />
4. What would happen if I were to lose money?<br />
If your ‘B’ Shares are disposed of at a loss (to the subscription price) the allowable loss for capital gains<br />
tax purposes is calculated by reducing that loss by the amount of the EIS income tax relief. <strong>The</strong> reduced<br />
loss can be set against gains or by election against your income.<br />
<strong>The</strong> examples given in this section are illustrative only and assume that at all relevant times the Company<br />
qualifies for EIS relief. <strong>The</strong>y are not and should not be construed as forecasts of the likely performance<br />
of the investment described in this Prospectus.<br />
Management Incentives<br />
<strong>The</strong> major objective of the Company will be to maximise its capital value and the Directors consider that it<br />
is in the interests of the Company and its shareholders that suitable incentives be provided to the Directors.<br />
Accordingly the Directors, David Fairman and Jon Morrey will each hold 22,000 ‘A’ Shares, and Lee Friend<br />
will hold 6,000 ‘A’ Shares.<br />
Set out below is a summary of the rights pertaining to dividend distributions attaching to the ‘A’ Shares<br />
and the ‘B’ Shares and also to the rights attaching to the ‘A’ Shares and the ‘B’ Shares on a return of<br />
assets. Further information on the rights attaching to the ‘A’ Shares and the ‘B’ Shares are set out in<br />
paragraph 4 of the Statutory & General Information section to this document.<br />
Dividend distributions<br />
If a dividend is declared all shareholders will be entitled to participate equally (pro rata to the number<br />
of shares held by each shareholder) in the dividend up to the amount of the issued nominal amount of<br />
the share capital of the Company at the date of such dividend. Assuming the Offer is fully subscribed and<br />
that there are 50,000 ‘A’ Shares in issue, if the amount of the dividend exceeds £2,050,000, then the<br />
excess amount will be distributed to shareholders as follows:<br />
Distributions by way of dividend ‘A’ Shares ‘B’ Shares<br />
Any dividend up to such time as the aggregate<br />
total dividend has reached £2,050,000 2.44% 97.56%<br />
Any dividend distribution after the aggregate<br />
total dividend has reached £2,050,000 50% 50%<br />
Return of assets<br />
On a return of assets on a liquidation, reduction of capital or otherwise (after payment of all liabilities)<br />
all shareholders will be entitled to participate equally (pro rata to the number of shares held by each<br />
shareholder) in the return of assets up to the amount of the issued nominal amount of the share capital<br />
of the Company at the date of such return of assets. Assuming the Offer is fully subscribed and that there<br />
are 50,000 ‘A’ Shares in issue, if the value of the assets returned to shareholders exceeds £2,050,000, then<br />
the excess amount will be distributed to shareholders as follows:<br />
Return of assets to shareholders ‘A’ Shares ‘B’ Shares<br />
Any return of assets up to such time as the aggregate<br />
total payment to shareholders has reached £2,050,000 2.44% 97.56%<br />
Any return of assets distribution after the aggregate<br />
total payment to shareholders has reached £2,050,000 50% 50%<br />
Risk Factors<br />
<strong>The</strong> principal risk factors perceived to be relevant by the Directors are:<br />
1. <strong>The</strong> Company will be operating in a competitive industry where the commercial risks are high.<br />
Audience reaction, initial reviews and public taste cannot be predicted with certainty. Accordingly,<br />
an investment in the Company, as with many film, television or stage productions, is speculative and<br />
Investors may not get back the amount of their original investment.<br />
2. If only the minimum is raised there is no guarantee that further funds will be raised through presales<br />
or otherwise.<br />
3. Changes in government or government policy could affect the return on the Investors’ investment<br />
in the Company and may result in changes in tax rates and reliefs.<br />
4. Neither the Company, the Directors nor the Company’s advisors give any warranties or undertakings<br />
that EIS Relief or EIS Deferral Relief will be available or that if given, such relief will not be withdrawn.<br />
5. <strong>The</strong> Director and the Producers on the film have been contracted. Whilst the director of<br />
photography, editor, sound mixer, casting director, special effects supervisor and publicist on whom<br />
information has been given in this Prospectus have agreed in principle to work on the Film, no<br />
contracts have been entered into between any of them and the Company. It is intended that<br />
contracts will be finalised following the successful close of the Offer. However it should further be<br />
recognised that it is possible that a different crew to that outlined in this Prospectus may have to be<br />
employed, particularly if less than the full amount of the Offer is raised.<br />
6. Though negotiations with an established US sales agent have commenced, no international sales<br />
agent has yet been appointed by the Company.<br />
7. Investors wishing to obtain EIS income tax relief must retain their shares for three years from the<br />
date of issue. If the shares are not held for such three year period, the tax reliefs obtained initially<br />
will be lost, and must be repaid with interest. EIS Deferral Relief is withdrawn on a disposal of shares.<br />
Accordingly, for Investors wishing to obtain EIS Relief or EIS Deferral Relief, investment in the<br />
Company is not suitable as a short-term investment. In addition, there are various additional<br />
conditions attached to EIS Relief and EIS Deferral Relief which individual Investors must satisfy for<br />
specified periods and it is therefore vital that potential Investors take advice from their own<br />
professional advisers on the likelihood of their qualifying for EIS Relief or EIS Deferral Relief.<br />
8. Provisional clearance has been requested from the Inland Revenue in respect of the qualifying status<br />
of the Company for EIS purposes. <strong>The</strong>refore, whilst the Directors intend that Investors should obtain<br />
tax relief on their investment, no guarantee is given that such relief will be obtained.<br />
9. It is not the Directors’ intention to place the shares on any market in the foreseeable future.<br />
10. Prospective Investors are also reminded that:<br />
(i) investment in unquoted shares and stock carries higher risks than investment in quoted stocks.<br />
An investment in unquoted shares or stock may be difficult to realise and proper information for<br />
determining the value of the shares may not be available;<br />
(ii) the value of stocks or shares may go down as well as up.<br />
11. <strong>The</strong> investment offered in this document may not be suitable for all recipients and investors are<br />
accordingly strongly advised to consult a person authorised under the Financial Services and Markets<br />
Act 2000 who specialises in advising on the acquisition of shares and other securities.<br />
12. If the Minimum Amount is not raised within 40 days of the issue of this Prospectus, the Film will not<br />
proceed, and applicants will be refunded their subscription money in full.
28<br />
Statutory & General Information Statutory & General Information 29<br />
1. <strong>The</strong> Company<br />
(a) <strong>The</strong> Company was incorporated and registered in England and Wales on 27 August 2003 under the<br />
Act as a public limited company with the name Grosvenor Films Plc and its registered number is<br />
4877825. <strong>The</strong> principal legislation under which the Company operates is the Act and the regulations<br />
made thereunder.<br />
(b) <strong>The</strong> Company’s registered office is at Sovereign House, 212-224 Shaftesbury Avenue, London WC2H 8HQ.<br />
(c) <strong>The</strong> liability of the members of the Company is limited.<br />
(d) <strong>The</strong> Company is not a member of a group within the meaning of the Act.<br />
2. Share Capital<br />
(a) <strong>The</strong> authorised share capital of the Company is £4,000,000 divided into 100,000 ‘A’ Shares and<br />
3,900,000 ‘B’ Shares. <strong>The</strong> issued share capital of the Company is 6,000 ‘A’ Shares fully paid and 44,000<br />
‘A’ Shares partly paid as to 27p each.<br />
(b) By written resolution dated 19 September 2003:<br />
(i) the Directors were authorised generally and unconditionally pursuant to and in accordance with<br />
section 80 of the Act to exercise all the powers of the Company to allot relevant securities (within<br />
the meaning of that section) up to an aggregate nominal amount of £3,950,000 such authority to<br />
expire on the day prior to the fifth anniversary of the passing of the resolution, save that the<br />
Company may pursuant to the authority make offers or agreements before the expiry of the<br />
authority which would or might require equity securities to be allotted after such expiry, and the<br />
Directors may allot equity securities in pursuance of such offers or agreements as if the power<br />
conferred thereby had not expired;<br />
(ii) the Directors were empowered, pursuant to Section 95 of the Act, to allot equity securities (as<br />
defined in section 94(2) of the Act) for cash pursuant to the authority referred to in sub-paragraph<br />
(i) above as if section 89(1) of the Act did not apply to any such allotment, provided that such power<br />
shall expire on the day prior to the fifth anniversary of the passing of the resolution, save that the<br />
Company may before such expiry make an offer or agreement which would or might require<br />
relevant securities to be allotted after such expiry and the Directors may allot relevant securities in<br />
pursuance of such offer or agreement as if the authority conferred hereby had not expired.<br />
(c) Return of Capital<br />
On a return of assets on a liquidation, reduction of capital or otherwise, the holders of the ‘A’ Shares<br />
and the holders of the ‘B’ Shares shall be entitled to be paid out of the surplus assets of the Company<br />
remaining after payment of its liabilities the amount paid up or credited as paid up on the shares,<br />
such payment to be paid in proportion to the number of ‘A’ Shares or ‘B’ Shares held respectively by<br />
the holders of the ‘A’ Shares or the ‘B’ Shares (as the case may be). After such payment has been<br />
made to the holders of the ‘A’ Shares and the holders of the ‘B’ Shares any further surplus assets shall<br />
be paid as follows:<br />
(i) 50 per cent in value of such surplus assets shall be paid to the holders of the ‘A’ Shares in<br />
proportion to the number of ‘A’ Shares held by each of them; and<br />
(ii) 50 per cent in value of such surplus assets shall be paid to the holders of the ‘B’ Shares in<br />
proportion to the number of ‘B’ Shares held by each of them.<br />
(d) Redemption<br />
<strong>The</strong> shares are not redeemable.<br />
(e) Transfer of Shares<br />
Subject to such of the restrictions contained in the Articles as may be applicable, any member may<br />
transfer all or any of his shares by an instrument of transfer in any usual or common form or in any<br />
other form which the Directors may approve. Where companies legislation allows, shares in the<br />
Company may be transferred without a written instrument pursuant to procedures adopted for the<br />
purpose by the Directors. Any instrument of transfer of a share shall be signed by or on behalf of<br />
the transferor and, except in the case of fully-paid shares, by or on behalf of the transferee. <strong>The</strong><br />
Directors may in their absolute discretion and without giving any reason refuse to register any<br />
transfer of shares (not being fully paid shares). <strong>The</strong> Directors may also refuse to register a transfer<br />
of shares unless the instrument of transfer:-<br />
(i) is lodged (duly stamped if so required by law in order to be registered) at the Company’s<br />
registered office or at such other place as the Directors may appoint accompanied by the relevant<br />
share certificate(s);<br />
(ii) is in respect of only one class of share; and<br />
3. Memorandum of Association<br />
<strong>The</strong> memorandum of association of the Company provides that its principal objects are, inter alia, to<br />
carry on business as film and television makers, film producers, film directors, consultants and<br />
technicians of every description. <strong>The</strong> objects of the Company are set out in full in clause 4 of the<br />
Company’s Memorandum of Association which is available for inspection at the address specified in<br />
paragraph 16 below.<br />
4. Summary of Share Rights<br />
<strong>The</strong> articles of association of the Company, which are available for inspection, at the address<br />
specified in paragraph 16 below, contain provisions, inter alia, to the following effect:<br />
(a) Voting<br />
Whatever the number of ‘A’ Shares in issue at any time the ‘A’ Shares shall confer upon the holders<br />
thereof the right (pro rata to the number of ‘A’ Shares held by each of them) to cast an aggregate<br />
of 51 per cent of the voting rights capable of being cast on all matters decided by vote at general<br />
meetings of the Company.<br />
(b) Dividends<br />
Following payment of an aggregate total dividend of £1 in respect of each share in issue any further<br />
dividends shall be paid as follows:<br />
(i) 50 per cent in value of such dividends shall be paid to the holders of the ‘A’ Shares in proportion<br />
to the number of ‘A’ Shares held by each of them; and<br />
(ii) 50 per cent in value of such dividends shall be paid to the holders of the ‘B’ Shares in proportion<br />
to the number of ‘B’ Shares held by each of them.<br />
(f)<br />
(iii) is in favour of not more than four persons jointly.<br />
<strong>The</strong> Directors may also decline to register any transfer of shares on which the Company has a lien or<br />
which is made in favour of an infant, bankrupt or person of unsound mind.<br />
Where, in respect of any shares, any registered holder or any person appearing to be interested in<br />
such shares fails to comply with any notice given by the Company under Section 212 of the Act, then,<br />
provided that the shares concerned represent at least 0.25 per cent in nominal value of the issued<br />
shares of the relevant class, the Company may prohibit the transfers of such shares.<br />
<strong>The</strong> instrument of transfer of a share shall be signed by or on behalf of the transferor, and the<br />
transferor shall be deemed to remain the holder of the share until the name of the transferee is<br />
entered in the register in respect thereof. In the case of a partly paid up share the instrument of<br />
transfer must also be signed by or on behalf of the transferee.<br />
Suspension of Rights<br />
No member shall unless the Board otherwise determines be entitled to vote at general meetings<br />
either personally or by proxy if he or any person appearing to be interested in those shares has been<br />
duly served with a notice under Section 212 of the Act and he or any such person in the absolute<br />
discretion of the Board (i) is in default of supplying the Company with the information thereby<br />
requested within 21 days after service of such notice or such longer period as may be specified in<br />
such notice for compliance with, and (ii) has not remedied such default within a further period of<br />
14 days after service of a further notice requiring him to do so.
30<br />
Statutory & General Information Statutory & General Information 31<br />
(g)<br />
Variation of Rights<br />
Subject to the provisions of the Act, if at any time the capital of the Company is divided into<br />
additional different classes of shares, the rights attached to any class may be varied or abrogated,<br />
whether or not the Company is being wound up, either:<br />
7. Minimum Amount<br />
<strong>The</strong> Minimum Amount which, in the opinion of the Directors, must be raised for the purposes<br />
mentioned in paragraph 21 of Schedule 1 to the Regulations is as follows:-<br />
(i) in such manner (if any) as may be provided by such rights; or<br />
(ii) in the absence of any such provision with the consent in writing of the holders of three quarters<br />
in nominal value of the issued shares of that class, or with the sanction of an extraordinary<br />
resolution passed at a separate general meeting of the holders of the shares of that class. To every<br />
such meeting all the provisions of the Articles relating to general meetings or the proceedings<br />
thereat shall, so far as applicable and with the necessary modifications, apply, except that the<br />
necessary quorum shall be two persons at least, holding or representing by proxy one-third in<br />
nominal amount of the issued shares of the class in question and that any holder of the class in<br />
question present in person or by proxy may demand a poll.<br />
5. Directors’ Interests<br />
(a) <strong>The</strong> interests, all of which are beneficial, of each Director (including any interest known to that<br />
Director or which could with reasonable diligence be ascertained by him of any person connected<br />
with a Director within the meaning of section 346 of the Act) in the shares which immediately<br />
following the Offer will be notified to the Company pursuant to sections 324 and 328 of the Act or<br />
will be required pursuant to section 325 of the Act to be entered in the register referred to therein<br />
are as follows:-<br />
• David Fairman is a director of Flamingo Films Limited.<br />
• Lee Friend is a director of <strong>The</strong> Pack Shot Company Limited.<br />
Director<br />
David Fairman<br />
Jon Morrey<br />
Lee Friend<br />
Number of Shares<br />
22,000 ‘A’ Shares<br />
22,000 ‘A’ Shares<br />
6,000 ‘A’ Shares<br />
(b) Save as disclosed above, at the date of this document, no Director has any interest, beneficial or<br />
otherwise, in the share capital of the Company.<br />
(c) Save as disclosed in this document, no Director has or has had any interest in any transaction which<br />
is or was unusual in its nature or conditions or significant with regard to the business of the<br />
Company.<br />
6. Directors’ Service Contracts, Remuneration and Benefits in Kind<br />
(a) Each of the Directors has entered into a letter of engagement with the Company, the material terms<br />
of which are as follows:<br />
(i) each of the Directors agrees to give sufficient time to undertake his duties as a Director of the<br />
Company;<br />
(ii) the Directors will be entitled to a salary as follows:<br />
David Fairman Full Time £30,000 per annum<br />
Jon Morrey Full Time £30,000 per annum<br />
Lee Friend Part Time £15,000 per annum<br />
and the Company will reimburse all reasonable expenses incurred by each Director; and<br />
(iii) each Director will be appointed for an initial duration of two years, after which either the<br />
Director or the Company may terminate the agreement by giving six months’ written notice to the<br />
other party.<br />
(b) It is estimated that the aggregate remuneration (including benefits in kind) of the Directors for the<br />
year ending on 31 August 2004 under the arrangements in force at the date of this document will not<br />
exceed £75,000.<br />
<strong>The</strong> purchase price of any property purchased or to be purchased which<br />
is to be defrayed out of the proceeds of the Offer:<br />
Preliminary expenses and commissions: £30,000<br />
Repayment of monies borrowed in respect of the foregoing:<br />
Working Capital: £70,000<br />
Total: £100,000<br />
<strong>The</strong> total amount of the preliminary expenses (less commissions) of the Offer is estimated at £24,000<br />
which is payable out of subscriptions to the Offer. Assuming full subscription for all the ‘B’ Shares to<br />
be subscribed under the Offer, the total amount of commissions payable to financial intermediaries<br />
is expected to be approximately £100,000. <strong>The</strong> total proceeds which are expected to be raised by the<br />
Offer, assuming full subscription for all the ‘B’ shares to be subscribed under the Offer, is £2,000,000<br />
and on this basis the expected net proceeds after deduction of professional commissions to financial<br />
intermediaries is expected to be £1,900,000.<br />
If the Offer is not taken up in full the amount of the capital of the Company subscribed for thereunder<br />
will be allotted provided the Company receives not less than the Minimum Amount.<br />
8. Substantial Shareholdings<br />
<strong>The</strong> Company is not aware of any person who, immediately following the Offer will be interested in<br />
3 per cent or more of the issued share capital of the Company.<br />
9. Litigation<br />
<strong>The</strong> Company is not or has not been engaged in any legal or arbitration proceedings which may<br />
have, or have had, a significant effect on the Company’s financial position nor, so far as the Company<br />
is aware, are there any such proceedings pending or threatened by or against the Company.<br />
10. Principal Activities<br />
<strong>The</strong>re have been no exceptional factors which may have or have had a significant effect on the<br />
activities of the Company.<br />
11. Significant Developments<br />
<strong>The</strong>re have been no significant developments concerning the business of the Company since its<br />
incorporation other than the matters stated in this Prospectus.<br />
12. Current Prospects<br />
<strong>The</strong> Directors consider that the prospects of the Company for the financial year ending 31 August<br />
2004 are satisfactory.<br />
13. Intellectual Property<br />
Save as described in paragraph 15 below the Company is not dependent on any patents or other<br />
intellectual property rights, licences or contracts, which are of fundamental importance to its business.<br />
14. <strong>Tax</strong>ation of Dividends<br />
<strong>The</strong> statements that follow are intended only as a general guide to current law and practice for<br />
certain categories of shareholder. Anyone who is in any doubt as to his tax position or who is subject<br />
to tax in any jurisdiction other than the UK should consult an appropriate professional adviser.<br />
Under current UK taxation legislation no withholding tax will be deducted from dividends paid by<br />
the Company.<br />
A U.K. resident individual shareholder will receive, imputed to any dividend received from the<br />
Company, a tax credit equal to one ninth of the dividend paid. <strong>The</strong> dividend and tax credit will be<br />
included in calculating the shareholder’s total income for U.K. taxation purposes. <strong>The</strong> tax credit will<br />
satisfy in full the shareholder’s liability to income tax on the dividend plus the tax credit unless the<br />
Nil<br />
Nil
32<br />
Statutory & General Information UK <strong>Tax</strong>ation & EIS Legislation 33<br />
individual’s total income exceeds the threshold for higher rate tax in which case the individual will,<br />
to that extent, be liable to tax at the schedule F upper rate in respect of the dividend. <strong>The</strong> individual<br />
will pay additional tax on the dividend and related tax credit at a rate currently equal to 22.5 per cent.<br />
A U.K. resident corporate shareholder will not normally be liable to U.K. corporation tax on any<br />
dividend received from the Company and the dividend and associated tax credit will represent<br />
franked investment income in the hands of such a shareholder.<br />
A shareholder of the Company who is not resident in the U.K. is not generally entitled to the benefit<br />
of any tax credit in respect of a dividend received from the Company. However, such a shareholder may<br />
be entitled to reclaim from the Inland Revenue a proportion of the tax credit relating to the dividend<br />
if there is an appropriate provision in an applicable double taxation treaty or if the shareholder is a<br />
Commonwealth citizen or falls into certain other categories. A non U.K. resident shareholder may be<br />
subject to foreign taxation on dividend income in his country of residence. Any person who is not<br />
resident in the U.K. should consult his own tax adviser on whether he is entitled to reclaim any part of<br />
the tax credit, the procedure for doing so and the tax treatment of his country of residence.<br />
15. Material Contracts<br />
<strong>The</strong> following contracts (not being entered into in the ordinary course of business) have been<br />
entered into by the Company since its incorporation and are or may be material:<br />
(a) <strong>The</strong> Company has entered into a contract dated 22 September 2003 with David Fairman whereby<br />
David Fairman has entered into an option in favour of the Company in respect of providing his<br />
services as director of the Film.<br />
(b) <strong>The</strong> Company has entered into contracts dated 22 September 2003 with Jon Morrey, Lynda Cope and<br />
David Fairman whereby they have each entered into an option in favour of the Company in respect<br />
of providing their services as producers of the Film.<br />
(c) <strong>The</strong> Company has entered into an agreement dated 22 September 2003 with Flamingo Films Limited<br />
for the transfer to the Company of the option rights in the <strong>Messages</strong> screenplay and television series.<br />
16. Documents for Inspection<br />
Copies of the following documents may be inspected at the registered office of the Company and<br />
at the offices of Bourner Bullock, Sovereign House, 212-224 Shaftesbury Avenue, London WC2H 8HQ<br />
during usual business hours on any weekday (Saturdays, Sundays and public holidays excepted) up<br />
to and including the date on which the Offer closes:<br />
(a) <strong>The</strong> memorandum and articles of association of the Company<br />
Summary of EIS Legislation<br />
This is a summary of the main provisions of the Enterprise Investment Scheme so far as relevant to the<br />
Company as set out in Section 289 and subsequent sections of ICTA 1988, Schedule 5B of TCGA 1992, and<br />
other relevant legislation. It does not set out any of the provisions in full and intending Investors are<br />
strongly advised to seek professional advice as to the tax relief that their particular investment will<br />
attract and the tax consequences of selling or otherwise disposing of their shares.<br />
<strong>Tax</strong> Reliefs<br />
(a) Income <strong>Tax</strong><br />
EIS Relief allows qualifying individuals to deduct from their total liability to income tax an amount<br />
equal to tax at the lower rate on the price paid for the shares. EIS Relief is currently obtained at a<br />
rate of tax of 20% on qualifying investments up to £150,000 in any tax year. <strong>The</strong> spouse of a claimant<br />
is also entitled to claim EIS Relief on his/her own investments. EIS Relief is not given for investments<br />
of less than £500 in any one company in any one tax year.<br />
Relief can be carried back to the immediately preceding tax year where shares are issued before 6<br />
October in a tax year. <strong>The</strong> lower of one half of the investment and £25,000 can be treated as being<br />
paid in the preceding year subject to the limit for relief for that year not being exceeded.<br />
(b) Capital Gains <strong>Tax</strong><br />
Under EIS Relief there is no capital gains tax charged on a disposal of the shares in the company<br />
provided they have been held for at least three years.<br />
Under EIS Deferral Relief an investor may defer a charge to capital gains tax on a gain arising on the<br />
disposal of any asset by making a qualifying investment in the period commencing one year before<br />
and ending three years following the disposal. <strong>The</strong>refore gains realised up to 1 year after and 3 years<br />
before the qualifying investment may be deferred. <strong>The</strong> maximum gain that can be deferred is equal<br />
to the amount subscribed but an investor can specify a lesser amount. <strong>The</strong> EIS Relief from capital<br />
gains tax on the disposal of EIS shares does not prevent the deferred gain becoming chargeable on<br />
their disposal.<br />
(c) Loss Relief<br />
If the shares are disposed of at a loss (to the subscription price) the allowable loss for capital gains<br />
tax purposes is calculated after reducing the cost by the amount of the EIS income tax relief. <strong>The</strong><br />
reduced loss can be set against gains or if there are none, then against an investor’s income.<br />
(b) <strong>The</strong> report of the Auditors<br />
(c) <strong>The</strong> letters of engagement entered into by the Company and each of the Directors<br />
(d) A copy of the material contracts referred to in paragraph 15 above.<br />
17. General<br />
<strong>The</strong> Offer is not being underwritten.<br />
<strong>The</strong> Auditors and reporting accountants for the purposes of the Offer are Bourner Bullock.<br />
Bourner Bullock has given and not withdrawn its written consent to the inclusion in the Prospectus<br />
of its report, the references thereto and the reference to its name in the form and context in which<br />
it appears and accepts responsibility for such report in accordance with paragraph 45 of Schedule 1<br />
to the Regulations.<br />
Basic Rules<br />
EIS Relief and EIS Deferral Relief can be claimed by qualifying individuals (and certain trustees in respect<br />
of EIS Deferral Relief only) who subscribe for new eligible shares in a qualifying unquoted company. <strong>The</strong><br />
shares cannot carry any preferential rights to dividends, to the company’s assets on a winding up nor may<br />
there be a right to redeem the shares. <strong>The</strong> shares must be issued fully paid up and along with all the<br />
shares comprised in the same issue be issued for the purpose of raising money for a qualifying business<br />
activity carried on by a qualifying company. 80% of the proceeds of the issue must be used wholly for<br />
the purposes of the qualifying activity within 12 months of the share issue (or commencement of the<br />
activity if later) and the balance within the next 12 months. <strong>The</strong> shares must be subscribed for, and issued,<br />
for bona fide commercial purposes and not as part of arrangements the main purpose or one of the main<br />
purposes of which is the avoidance of tax.
34<br />
UK <strong>Tax</strong>ation & EIS Legislation UK <strong>Tax</strong>ation & EIS Legislation 35<br />
Persons Qualifying for Relief<br />
(a) Income <strong>Tax</strong><br />
An individual need not be UK resident but the EIS Relief is only available against UK taxable income.<br />
An individual must not be connected with the company at any time in the period beginning two<br />
years before the issue of the shares and ending immediately before the third anniversary of the issue<br />
date, or if relevant the third anniversary of the date of commencement of the relevant qualifying<br />
business activity.<br />
(b)<br />
<strong>The</strong> main rules relating to “connection” with a company are that the individual and/or his or her<br />
associates must not:<br />
(i) be an employee, partner or paid director of the company or any subsidiary, or<br />
(ii) directly or indirectly possess or be entitled to acquire more than 30% of the issued ordinary share<br />
capital, the loan capital or the voting power of the company or any subsidiary, or<br />
(iii) possess directly or indirectly such rights as would, in the event of the winding up of the company<br />
or any subsidiary or in any other circumstances, entitle him to receive more than 30% of the assets<br />
of the company or any subsidiary which would then be available for distribution to equity holders<br />
(shareholders and certain loan capital holders).<br />
For this purpose an associate includes a husband or wife, lineal ancestor or descendent, a partner<br />
and certain persons with whom the individual has a connection through a trust.<br />
A director is not disqualified if he or she is reimbursed travelling and other expenses allowable for<br />
tax purposes, but generally he or she must not be entitled to remuneration. In limited circumstances,<br />
directors previously unconnected with the company or its trade may qualify for relief provided that<br />
their remuneration is reasonable.<br />
Capital Gains <strong>Tax</strong><br />
An individual must be resident or ordinarily resident in the UK at the time of the accrual of the<br />
capital gain and at the time when he makes the qualifying investment. If UK resident or ordinarily<br />
resident they must also not be regarded for the purposes of any tax treaty as resident in another<br />
country. UK resident trustees of discretionary trusts (if all the beneficiaries are individuals) and UK<br />
resident trustees of interest in possession settlements (to the extent that individuals hold the<br />
interests in possession) may claim EIS Deferral Relief provided that the asset disposed of which gives<br />
rise to the gain and the shares acquired are held on the terms of the same trusts.<br />
Qualifying Companies<br />
To be a qualifying company, the company must be an unquoted company at the time shares are issued<br />
and there must be no arrangements at that time for the company to cease to be unquoted. Provided<br />
there are no such arrangements at the time the shares are issued, a company can become an unquoted<br />
company at a later time and remain a qualifying company. It need not be UK resident. <strong>The</strong> company must<br />
not be controlled by another company nor must it control another company unless that other company<br />
is a qualifying subsidiary. <strong>The</strong> company must exist wholly for the purpose of carrying on one or more<br />
qualifying trades (other than to the extent that other purposes have no significant effect on those<br />
trading activities). Alternatively the qualifying company can be the parent company of a trading group<br />
whose aggregate activities must consist wholly of carrying on one or more qualifying trades (other than<br />
to the extent that other purposes have no significant effect on those trading activities). Any qualifying<br />
trade must be carried on wholly or mainly in the UK. <strong>The</strong> funds raised must be used for the purposes of<br />
the qualifying business activities of the relevant company. <strong>The</strong> value of a qualifying company’s gross<br />
assets (group’s aggregate assets if the parent of a trading group) immediately before a share issue must<br />
be no more than £15 million before the share issue and no more than £16 million after the issue. <strong>The</strong><br />
Board of Directors has undertaken, so far as it is within their power to do so, to ensure that the<br />
Company’s affairs will be conducted so as to obtain and maintain qualifying status under the EIS<br />
throughout the relevant period.<br />
Claims<br />
Investors make a formal claim for the EIS Relief or EIS Deferral Relief from their inspector of taxes. <strong>The</strong><br />
claim is made on receipt of Form EIS 3 from the company. Form EIS 3 is a certificate issued by a company,<br />
with the approval of the Inland Revenue, confirming that it is a qualifying company for these purposes.<br />
A company cannot seek the Inland Revenue’s approval until it has carried on a qualifying activity for four<br />
months. <strong>The</strong> approval must be sought within two years of the end of the year of assessment in which the<br />
shares are issued or, if later, within two years of the period commencing with the date on which the<br />
company completed its first four months of trading. An investor’s claim must be submitted to his tax<br />
inspector no later than the fifth anniversary of 31 January following the year of assessment in which the<br />
shares were issued (or treated as issued if relief is carried back). <strong>The</strong> Company proposes to submit its<br />
application to the Inland Revenue to issue EIS 3 as soon as it is practicable.<br />
Withdrawal of Relief<br />
<strong>The</strong>re are a number of anti-avoidance provisions that can apply to both EIS Relief and EIS Deferral Relief<br />
which are beyond the scope of this summary.<br />
(a) Income <strong>Tax</strong><br />
If the company ceases to be a qualifying company within the three years commencing with the issue<br />
of the shares (or commencement of the qualifying trade if later) all EIS Relief is withdrawn. If shares<br />
are disposed of within three years of their issue relief is withdrawn in respect of those shares to the<br />
extent of the amount or value of the consideration received for them unless the disposal is not at<br />
arm’s length when all relief in respect of them is withdrawn. EIS Relief will be withdrawn if value is<br />
received by an investor from the company or a person connected with the company, or in more<br />
limited circumstances by other shareholders, within the period commencing one year before the<br />
share issue and ending three years after it (or three years after the commencement of the qualifying<br />
trade if later). <strong>The</strong> circumstances in which value is received for these purposes are extensive although<br />
it may be disregarded if the value received is insignificant or the original supplier of value to an<br />
investor receives replacement value.<br />
(b) Capital Gains <strong>Tax</strong><br />
<strong>The</strong> gain that is deferred becomes a chargeable gain when an investor disposes of the shares (other<br />
than to a spouse) or ceases to be resident within the 3 years commencing with the issue of the shares<br />
(or commencement of the qualifying trade if later). EIS Deferral Relief is withdrawn if the company<br />
ceases to be a qualifying company; the company ceases to carry on the qualifying business activity,<br />
or the proceeds of the share issue are not used within the time limit, the deferred gain is deemed<br />
to arise on the date on which these circumstances arise. EIS Deferral Relief will be withdrawn if value<br />
is received by an investor from the company or a person connected with the company or in more<br />
limited circumstances by other shareholders, within the period commencing one year before the<br />
share issue and ending three years after it (or three years after the commencement of the qualifying<br />
trade if later). <strong>The</strong> circumstances in which value is received for these purposes are extensive although<br />
it may be disregarded if the value received is insignificant.
36<br />
Accountant’s <strong>Report</strong> Accountant’s <strong>Report</strong> 37<br />
Grosvenor Films Plc<br />
Ealing Studios<br />
Ealing Green<br />
London W5 5EP<br />
Bourner Bullock<br />
Sovereign House<br />
212/224 Shaftesbury Avenue<br />
London WC2H 8HQ<br />
2.3.4 On 19 September 2003, the 50,000 issued ordinary shares of £1 each were re-designated as ‘A’ shares<br />
of £1 each and the authorised share capital of the company was increased from £50,000 to £4,000,000<br />
by the creation of a further 50,000 ‘A’ shares of £1 each and 3,900,000 ‘B’ shares of £1 each.<br />
2.3.5 On 22 September 2003, the directors entered into service agreements with Grosvenor Films Plc, the<br />
material terms of which are:<br />
Dear Sirs<br />
GROSVENOR FILMS PLC<br />
10 October 2003<br />
1 Introduction<br />
We report on the financial information set out in paragraphs 2 to 5 below. This financial<br />
information has been prepared for inclusion in the prospectus dated 21 October 2003 of<br />
Grosvenor Films Plc (“the company”).<br />
1.1 Basis of preparation<br />
<strong>The</strong> financial information set out in paragraphs 2 to 5 is based on the transactions of the company<br />
for the period from incorporation on 27 August 2003 to 23 September 2003. No adjustments were<br />
considered necessary.<br />
1.2 Responsibility<br />
<strong>The</strong> Directors of Grosvenor Films Plc are responsible for the contents of the prospectus dated 21<br />
October 2003 in which this report is included. It is our responsibility to form an opinion on the<br />
financial information and to report our opinion to you.<br />
1.3 Basis of opinion<br />
We conducted our work in accordance with the Statements of Investment Circular <strong>Report</strong>ing<br />
Standards issued by the Auditing Practices Board. Our work included an assessment of evidence<br />
relevant to the amounts and disclosures in the financial information.<br />
We planned and performed our work so as to obtain all the information and explanations which<br />
we considered necessary in order to provide us with sufficient evidence to give reasonable<br />
assurance that the financial information is free from material misstatement whether caused by<br />
fraud or other irregularity or error.<br />
1.4 Opinion<br />
In our opinion, the financial information gives, for the purpose of the prospectus dated 21 October<br />
2003, a true and fair view of the state of affairs of Grosvenor Films Plc as at 23 September 2003.<br />
1.5 Consent<br />
We consent to the inclusion in the prospectus dated 21 October 2003 of this report and accept<br />
responsibility for this report for the purposes of paragraph 45 of schedule 1 to the Public Offers of<br />
Securities Regulations 1995.<br />
2. Statutory information<br />
2.1 Grosvenor Films Plc was incorporated on 27 August 2003.<br />
2.2 <strong>The</strong> company has not completed its first accounting period. No statutory financial statements have<br />
been prepared, audited or filed with the Registrar of Companies since incorporation.<br />
2.3 As at 23 September 2003, the company had carried out no trading and the only transactions have<br />
been as follows:<br />
2.3.1 On incorporation, David Fairman, Jon Morrey and Lee Friend were appointed directors.<br />
2.3.2 On incorporation, 22,000 and 22,000 and 6,000 ordinary shares of £1 each were allotted to David<br />
Fairman, Jon Morrey and Lee Friend respectively.<br />
2.3.3 <strong>The</strong> issued ordinary shares were paid up on 11 September 2003 as follows:<br />
Ordinary shares of £1 each<br />
Shares allotted to Number Amount paid up £<br />
David Fairman 22,000 6,000<br />
Jon Morrey 22,000 6,000<br />
Lee Friend 6,000 6,000<br />
50,000 18,000<br />
• David Fairman, Jon Morrey and Lee Friend agreed to devote such time as necessary to the business<br />
of Grosvenor Films Plc.<br />
• <strong>The</strong> aggregate total salaries of the directors will not exceed the maximum of £75,000 for the year<br />
ending on 31 August 2003 and Grosvenor Films Plc will reimburse all reasonable expenses incurred<br />
by each director.<br />
2.3.6 On 22 September 2003, Grosvenor Films Plc entered into an option for producers’ services<br />
agreement in connection with the screenplay for the film with each of David Fairman, Jon Morrey<br />
and Lynda Cope.<br />
2.3.7 On 22 September 2003, the option rights to the screenplay for the film were transferred from Flamingo<br />
Films to Grosvenor Films Plc.<br />
2.3.8 On 22 September 2003, Grosvenor Films Plc entered in to an option agreement with David Fairman<br />
to become the director of the film<br />
3. Principal accounting policies<br />
3.1 Basis of accounting<br />
<strong>The</strong> balance sheet is prepared under the historical cost convention and in accordance with applicable<br />
accounting standards.<br />
4. Financial information as at 23 September 2003<br />
4.1 Balance sheet<br />
Current assets £<br />
Cash at bank and in hand 18,000<br />
Net Assets 18,000<br />
Capital and Reserves £<br />
Share Capital 18,000<br />
Shareholders’ funds 18,000<br />
5. Notes to the financial information<br />
5.1 Share capital<br />
Authorised £<br />
100,000 ‘A’ shares of £1.00 each 100,000<br />
3,900,000 ‘B’ shares of £1.00 each 3,900,000<br />
4,000.000<br />
Called up allotted and partly paid £<br />
50,000 ‘A’ shares of £1.00 each 18,000<br />
<strong>The</strong> ‘A’ and ‘B’ shares rank pari passu in all respects except as provided in article 6 of the company’s<br />
articles of association.<br />
Yours faithfully<br />
Bourner Bullock<br />
Chartered Accountants
✁<br />
38 Procedure for Application<br />
Application Form 39<br />
General conditions<br />
<strong>The</strong> purchase price for each ‘B’ Share is £1. Each application<br />
must be made on the application form supplied in this<br />
document and be accompanied by a separate cheque or<br />
bankers’ draft drawn in Sterling on an account at a branch<br />
(which must be in England, Scotland, Northern Ireland,<br />
Wales, the Channel Islands or the Isle of Man) of a bank or<br />
building society which is either a settlement member of the<br />
Cheque and Credit Clearing Company Limited or a member<br />
of either of the committees of the Scottish or Belfast<br />
Clearing Houses or which has arranged for its cheques and<br />
bankers drafts’ to be cleared through the facilities provided<br />
by either of those companies or those committees (and<br />
must bear the appropriate sorting code number in the top<br />
right hand corner).<br />
No person receiving a copy of this document and/or<br />
application form in any territory other than the United<br />
Kingdom may treat the same as constituting an invitation or<br />
offer to him, nor should he in any event use such<br />
application form, unless in the relevant territory such an<br />
invitation could lawfully be made to him or such form could<br />
lawfully be used without contravention of any other<br />
legislation or other legal requirements. It is the<br />
responsibility of any person outside the United Kingdom<br />
wishing to make an application hereunder to satisfy himself<br />
as to the full observance of the laws and regulations of the<br />
relevant territory in connection therewith including<br />
obtaining any governmental or other consents which may<br />
be required or observing any other formalities needing to<br />
be observed in such territory.<br />
This application form, together with your cheque or bankers’ draft made payable to Grosvenor Films Plc should be sent to<br />
Grosvenor Films Plc at Ealing Studios, Ealing Green, London W5 5EP. <strong>The</strong> Offer will open at 10am on 21 October 2003.<br />
<strong>The</strong> initial closing date is 28 November 2003. So long as the Minimum Amount shall have been raised by 5pm on 28 November<br />
2003, the Offer may then be extended by the Directors.<br />
Grosvenor Films plc<br />
Offer for subscription of up to 2,000,000 ‘B’ Shares payable in full on application<br />
Number of shares applied for*<br />
Amount enclosed at £1 per share<br />
*applications must be for a minimum of 2,000 ‘B’ Shares and thereafter in multiples of 1,000 ‘B’ Shares<br />
£<br />
Our Reference<br />
This application form and payment should then<br />
be forwarded by post or hand to:<br />
Grosvenor Films Plc<br />
Ealing Studios<br />
Ealing Green<br />
London W5 5EP<br />
Applicants are advised to allow three full business days for<br />
delivery through the post. Cheques or bankers’ drafts must<br />
be made payable to Grosvenor Films Plc and crossed A/C<br />
Payee. Applications must be for the minimum of two<br />
thousand ‘B’ Shares and thereafter in multiples of one<br />
thousand ‘B’ Shares. Share certificates will be despatched to<br />
shareholders as soon as possible following allotment. Share<br />
certificates and any surplus moneys will be retained<br />
pending clearance of an applicant’s cheque. Cheques will be<br />
presented for payment on receipt and kept in a designated<br />
account of the Company pending completion of the Offer<br />
and it is a term of the Offer that remittances should be<br />
honoured on the first presentation. <strong>The</strong> applicant, by<br />
completion of the application form, forgoes his right to any<br />
interest on the subscription monies.<br />
<strong>The</strong> Board reserves the right to reject any application for<br />
‘B’ Shares. <strong>The</strong> Board also reserves the right to treat as valid<br />
any applications for ‘B’ Shares, which do not fully comply<br />
with the conditions set out in the application form. If any<br />
application for ‘B’ Shares is not accepted or the Offer<br />
lapses, the amount paid on application will be returned<br />
within seven days of such rejection or lapse. All documents<br />
and remittances relating to this Offer sent by or to an<br />
applicant are at the applicant’s risk. Applications will be<br />
considered in order of receipt, save that applications<br />
received with post-dated cheques will not be considered<br />
until the date of the cheque.<br />
Joint applications are acceptable, but joint applicants<br />
should note that they might not be able to claim EIS Relief<br />
or EIS Deferral Relief. All joint applicants should sign the<br />
application form and give full names and addresses in block<br />
capitals. An applicant applying on behalf of another person<br />
must complete the application form in the name of that<br />
other person and sign his/her name as attorney and must<br />
enclose a power of attorney duly executed.<br />
<strong>The</strong> Offer will open at 10am on 21 October 2003. <strong>The</strong> initial<br />
closing date is 28 November 2003. So long as the Minimum<br />
Amount shall have been raised by 5pm on 28 November<br />
2003, the Offer may then be extended by the Directors.<br />
Further Terms and Conditions<br />
Your attention is drawn to the terms and conditions set out<br />
on the reverse of the application form which forms part of<br />
this document and to the application form.<br />
Important - Money Laundering Regulations<br />
It is a term of the Offer that, to ensure compliance with the<br />
Money Laundering Regulations 1993, the Company is<br />
entitled to require, at its absolute discretion, verification of<br />
the identity from any person lodging an application form<br />
for B Shares (“the Applicant”) including, without limitation,<br />
from any Applicant who either (i) tenders payment by way<br />
of a cheque or banker’s draft drawn on an account in the<br />
name of a person or persons other than the Applicant or (ii)<br />
appears to the Company to be acting on behalf of some<br />
other person. In the case of (i) above, verification of the<br />
identity of the Applicant may be required. In the case of (ii)<br />
above, verification of the identity of any person on whose<br />
behalf the Applicant appears to be acting may be required.<br />
Pending the provision of evidence satisfactory to the<br />
Company as to the identity of the Applicant and/or any<br />
person on whose behalf the Applicant appears to be acting,<br />
the Company may, in its absolute discretion, retain an<br />
application form lodged by an Applicant and/or the cheque<br />
or other remittance relating thereto and/or not enter the<br />
Applicant on the register of members or issue any certificate<br />
in respect of ‘B’ Shares allotted to the Applicant. If, within a<br />
reasonable period of time following request for verification<br />
of identity and in any case no later than 3pm on the<br />
relevant date of allotment, the Company has not received<br />
evidence of the identity of the Applicant satisfactory to it,<br />
the Company may, at its absolute discretion, reject any such<br />
application in which event the remittance submitted in<br />
respect of that application will be returned to the Applicant<br />
(without prejudice to the rights of the Company to<br />
undertake proceedings to cover any loss suffered by it as a<br />
result of the failure of the Applicant to produce satisfactory<br />
evidence of identity).<br />
To: <strong>The</strong> Directors, Grosvenor Films Plc<br />
I hereby irrevocably offer to subscribe for the number of fully paid ‘B’ Shares on the terms of the document dated<br />
21 October 2003 (the “Prospectus”) and subject to the terms and conditions set out on the next page and the memorandum<br />
and articles of association of the Company. I enclose a cheque/bankers’ draft for the amount specified above, made payable<br />
to Grosvenor Films Plc and agree to accept the same or such lesser number of such ‘B’ Shares in respect of which my<br />
application may be accepted.<br />
I request and authorise you to register any ‘B’ Shares for which this application is accepted in the name(s) set out below:<br />
Surname:<br />
Title:<br />
Forenames:<br />
Address:<br />
Tel:<br />
Fax:<br />
Signature:<br />
Date:<br />
Surname:<br />
Title:<br />
Forenames:<br />
Address:<br />
Tel:<br />
Fax:<br />
Signature:<br />
Date:<br />
All Joint applicants must sign (Note: Joint applicants may not be able to claim EIS Relief or EIS Referral Relief)<br />
Your cheque/bankers’ draft should be made payable to “Grosvenor Films Plc.”, If application is made through your agent,<br />
please complete below including occupation and authorisation.<br />
Agents name:<br />
Reference:<br />
Address:<br />
Authorisation code:<br />
Tel:
✁<br />
✁<br />
40<br />
Terms & conditions<br />
Duplicate Application Form 41<br />
1. I hereby acknowledge that the acceptance and basis of<br />
application of the ‘B’ Shares of the Company is in the<br />
absolute discretion of the Directors and that they have<br />
reserved the right to reject in whole or in part or to<br />
scale down any application including without limitation<br />
multiple or suspected multiple applications or any<br />
application considered by the Directors to have been<br />
made by a nominee. If any application is not accepted,<br />
or is accepted for fewer ‘B’ Shares, then the number<br />
applied for the application monies or the balance<br />
thereof (as the case may be) will be returned by sending<br />
the applicant’s cheque or bankers draft, or a crossed<br />
cheque in favour of the applicant in each case by post<br />
or by hand and at the risk of the person entitled thereto<br />
the address of the applicant without interest.<br />
2. In consideration of the Directors agreeing that they will<br />
consider and process applications for the ‘B’ Shares in<br />
accordance with the procedure referred to in the<br />
Prospectus and as a separate contract with the<br />
Company which will become binding on despatch by<br />
post of this application form:-<br />
a) I warrant that my cheque or bankers’ draft will be<br />
honoured on first presentation and agree that if such<br />
cheque or bankers’ draft is not so honoured I will not be<br />
entitled to receive a share certificate for any ‘B’ Shares<br />
unless and until I make payment in cleared funds for<br />
such ‘B’ Shares and such payment as accepted by the<br />
Company in its absolute discretion (which acceptance<br />
may be on the basis that I indemnify the Company<br />
against all cost, damages, losses, expenses and liabilities<br />
arising out of or in conjunction with the failure of my<br />
remittance to be honoured on the first presentation).<br />
b) I understand that any application by me to invest in the<br />
Company shall be deemed to be an offer up to the<br />
value of my application and that such offer shall be<br />
deemed to take effect on despatch by post with this<br />
application form.<br />
c) I confirm that I am not relying on any information or<br />
representation in relation to the Company other than<br />
that contained in the Prospectus and agree that neither<br />
the Company nor any person responsible for the<br />
Prospectus or any part of it shall have any liability for<br />
any information or representation not so contained.<br />
d) I hereby authorise the Company to send a cheque for<br />
any monies returnable to me by first class post at my<br />
risk to the address given overleaf or introducing agent.<br />
e) I agree that my application is irrevocable.<br />
h) I hereby warrant and declare that:<br />
(i) I am resident and ordinarily resident in UK and that I<br />
have been so resident and expect to remain so resident<br />
and I will notify the Directors immediately in writing if<br />
I cease to be so resident;<br />
(ii) I am not connected with the Company and I will notify<br />
the Directors immediately in writing if I become so<br />
connected as defined in section 291 of the Income and<br />
Corporation <strong>Tax</strong> Act, 1988;<br />
(iii) I agree that this application form shall be construed<br />
in accordance with and governed by the laws of<br />
England and Wales.<br />
3. I hereby declare that I have read a copy, understood and<br />
agreed to the terms and conditions contained in the<br />
Prospectus and this application form including the risk<br />
factors on pages 27 of the Prospectus and have taken all<br />
the appropriate professional advice which I consider<br />
necessary before submitting my application and that I<br />
am aware of the special risks involved in participating in<br />
an investment of this nature, and I understand that my<br />
application is made upon the terms of the Prospectus<br />
and this application form.<br />
4. I acknowledge that in relation to the transactions in the<br />
Prospectus, advisors of the Company mentioned therein<br />
are acting for the Company and not for me or on my<br />
account and that accordingly will not be responsible to<br />
me for providing protections afforded to their clients,<br />
for advising me on any transaction described herein, or<br />
for ensuring that any such transaction is suitable for me.<br />
5. I agree that acceptance of an application form will<br />
have the meaning set out in the Prospectus unless the<br />
context requires otherwise.<br />
This application form, together with your cheque or bankers’ draft made payable to Grosvenor Films Plc should be sent to<br />
Grosvenor Films Plc at Ealing Studios, Ealing Green, London W5 5EP. <strong>The</strong> Offer will open at 10am on 21 October 2003.<br />
<strong>The</strong> initial closing date is 28 November 2003. So long as the Minimum Amount shall have been raised by 5pm on 28 November<br />
2003, the Offer may then be extended by the Directors.<br />
Grosvenor Films plc<br />
Offer for subscription of up to 2,000,000 ‘B’ Shares payable in full on application<br />
Number of shares applied for*<br />
Amount enclosed at £1 per share<br />
*applications must be for a minimum of 2,000 ‘B’ Shares and thereafter in multiples of 1,000 ‘B’ Shares<br />
£<br />
Our Reference<br />
To: <strong>The</strong> Directors, Grosvenor Films Plc<br />
I hereby irrevocably offer to subscribe for the number of fully paid ‘B’ Shares on the terms of the document dated<br />
21 October 2003 (the “Prospectus”) and subject to the terms and conditions set out on the next page and the memorandum<br />
and articles of association of the Company. I enclose a cheque/bankers’ draft for the amount specified above, made payable<br />
to Grosvenor Films Plc and agree to accept the same or such lesser number of such ‘B’ Shares in respect of which my<br />
application may be accepted.<br />
I request and authorise you to register any ‘B’ Shares for which this application is accepted in the name(s) set out below:<br />
Surname:<br />
Title:<br />
Forenames:<br />
Address:<br />
Tel:<br />
Fax:<br />
Signature:<br />
Date:<br />
Surname:<br />
Title:<br />
Forenames:<br />
Address:<br />
Tel:<br />
Fax:<br />
Signature:<br />
Date:<br />
All Joint applicants must sign (Note: Joint applicants may not be able to claim EIS Relief or EIS Referral Relief)<br />
Your cheque/bankers’ draft should be made payable to “Grosvenor Films Plc.”, If application is made through your agent,<br />
please complete below including occupation and authorisation.<br />
f) I warrant that if I have signed this application form on<br />
behalf of any other person I have due authority to do so,<br />
and that such person will also be bound accordingly and<br />
be deemed to have given the confirmations, warranties<br />
and undertakings contained in this Prospectus.<br />
g) I warrant that I am not nor am I applying on behalf of<br />
a person who is under the age of 18.<br />
Grosvenor Films Plc<br />
Ealing Film Studios<br />
Ealing Green<br />
London W5 5EP<br />
Agents name:<br />
Reference:<br />
Address:<br />
Authorisation code:<br />
Tel:
✁<br />
42<br />
Terms & conditions<br />
1. I hereby acknowledge that the acceptance and basis of<br />
application of the ‘B’ Shares of the Company is in the<br />
absolute discretion of the Directors and that they have<br />
reserved the right to reject in whole or in part or to<br />
scale down any application including without limitation<br />
multiple or suspected multiple applications or any<br />
application considered by the Directors to have been<br />
made by a nominee. If any application is not accepted,<br />
or is accepted for fewer ‘B’ Shares, then the number<br />
applied for the application monies or the balance<br />
thereof (as the case may be) will be returned by sending<br />
the applicant’s cheque or bankers draft, or a crossed<br />
cheque in favour of the applicant in each case by post<br />
or by hand and at the risk of the person entitled thereto<br />
the address of the applicant without interest.<br />
2. In consideration of the Directors agreeing that they will<br />
consider and process applications for the ‘B’ Shares in<br />
accordance with the procedure referred to in the<br />
Prospectus and as a separate contract with the<br />
Company which will become binding on despatch by<br />
post of this application form:-<br />
a) I warrant that my cheque or bankers’ draft will be<br />
honoured on first presentation and agree that if such<br />
cheque or bankers’ draft is not so honoured I will not be<br />
entitled to receive a share certificate for any ‘B’ Shares<br />
unless and until I make payment in cleared funds for<br />
such ‘B’ Shares and such payment as accepted by the<br />
Company in its absolute discretion (which acceptance<br />
may be on the basis that I indemnify the Company<br />
against all cost, damages, losses, expenses and liabilities<br />
arising out of or in conjunction with the failure of my<br />
remittance to be honoured on the first presentation).<br />
b) I understand that any application by me to invest in the<br />
Company shall be deemed to be an offer up to the<br />
value of my application and that such offer shall be<br />
deemed to take effect on despatch by post with this<br />
application form.<br />
h) I hereby warrant and declare that:<br />
(i) I am resident and ordinarily resident in UK and that I<br />
have been so resident and expect to remain so resident<br />
and I will notify the Directors immediately in writing if<br />
I cease to be so resident;<br />
(ii) I am not connected with the Company and I will notify<br />
the Directors immediately in writing if I become so<br />
connected as defined in section 291 of the Income and<br />
Corporation <strong>Tax</strong> Act, 1988;<br />
(iii) I agree that this application form shall be construed<br />
in accordance with and governed by the laws of<br />
England and Wales.<br />
3. I hereby declare that I have read a copy, understood and<br />
agreed to the terms and conditions contained in the<br />
Prospectus and this application form including the risk<br />
factors on pages 27 of the Prospectus and have taken all<br />
the appropriate professional advice which I consider<br />
necessary before submitting my application and that I<br />
am aware of the special risks involved in participating in<br />
an investment of this nature, and I understand that my<br />
application is made upon the terms of the Prospectus<br />
and this application form.<br />
4. I acknowledge that in relation to the transactions in the<br />
Prospectus, advisors of the Company mentioned therein<br />
are acting for the Company and not for me or on my<br />
account and that accordingly will not be responsible to<br />
me for providing protections afforded to their clients,<br />
for advising me on any transaction described herein, or<br />
for ensuring that any such transaction is suitable for me.<br />
5. I agree that acceptance of an application form will<br />
have the meaning set out in the Prospectus unless the<br />
context requires otherwise.<br />
c) I confirm that I am not relying on any information or<br />
representation in relation to the Company other than<br />
that contained in the Prospectus and agree that neither<br />
the Company nor any person responsible for the<br />
Prospectus or any part of it shall have any liability for<br />
any information or representation not so contained.<br />
d) I hereby authorise the Company to send a cheque for<br />
any monies returnable to me by first class post at my<br />
risk to the address given overleaf or introducing agent.<br />
e) I agree that my application is irrevocable.<br />
f) I warrant that if I have signed this application form on<br />
behalf of any other person I have due authority to do so,<br />
and that such person will also be bound accordingly and<br />
be deemed to have given the confirmations, warranties<br />
and undertakings contained in this Prospectus.<br />
g) I warrant that I am not nor am I applying on behalf of<br />
a person who is under the age of 18.<br />
Grosvenor Films Plc<br />
Ealing Film Studios<br />
Ealing Green<br />
London W5 5EP